,id,adj.P.Val.xBirA.over.NoBirA,AveExpr.xBirA.over.NoBirA,Log.P.Value.xBirA.over.NoBirA,logFC.xBirA.over.NoBirA,P.Value.xBirA.over.NoBirA,t.xBirA.over.NoBirA,Brain_Searched..127.126.127.128.129.130.131..No_BirA_6.multimedian,Brain_Searched..128.126.127.128.129.130.131..No_BirA_5.multimedian,Brain_Searched..131.126.127.128.129.130.131..No_BirA_4.multimedian,Brain_Searched..126.126.127.128.129.130.131..XBirA_2.multimedian,Brain_Searched..129.126.127.128.129.130.131..XBirA_3.multimedian,Brain_Searched..130.126.127.128.129.130.131..XBirA_1.multimedian,id.query,id.mapped,id.concat,accession_number,geneSymbol,numColumnsProteinObserved,numSpectraProteinObserved,numPepsUnique,numPepsUniqueSubgroupSpecificCI,accession_numbers,species,protein_mw,percentCoverage,groupNum,subgroupNum,scoreUnique,scoreUniqueSubgroupSpecificCI,orfCategory,sequenceLength,entry_name,cellular_component,biological_process,molecular_function,Brain_Searched.unique_peptides,Brain_Searched.numSpectra,Brain_Searched.totalIntensity,Brain_Searched.pct_cov
3177,Q6NZC7,0.000321137,-0.009833333,48.59890769,2.944333333,1.38E-05,9.977521244,-1.718,-1.34,-1.388,1.854,0.718,1.815,Q6NZC7,NotFound,Q6NZC7_NotFound,Q6NZC7,Sec23ip,1,7,2,2,Q6NZC7|G3X928,MOUSE,111405.9,3.1,2703,2703.1,20.7,20.7,NA,998,SEC23-interacting protein,cis-Golgi network|ER to Golgi transport vesicle membrane|intracellular membrane-bounded organelle|perinuclear region of cytoplasm|endoplasmic reticulum exit site|perinuclear endoplasmic reticulum|,acrosome assembly|spermatid development|single fertilization|,poly(A) RNA binding|metal ion binding|,2,7,1.02E+09,3.10%
1038,Q9CQ45,6.49E-06,-0.637,87.21347781,2.928,1.90E-09,32.19520013,-1.994,-2.148,-2.161,0.92,0.759,0.802,Q9CQ45,Nenf,Q9CQ45_Nenf,Q9CQ45,Nenf,1,36,11,11,Q9CQ45,MOUSE,18904.1,66.6,676,676.1,186.05,186.05,NA,171,Neudesin,extracellular space|nucleus|nucleoplasm|endomembrane system|membrane|,negative regulation of appetite|positive regulation of MAPK cascade|,growth factor activity|heme binding|metal ion binding|,11,36,2.22E+10,66.60%
65,P08113,1.06E-05,-0.3075,71.55759454,2.657666667,6.99E-08,19.99556212,-1.736,-1.595,-1.578,1.121,0.738,1.205,P08113,Hsp90b1,P08113_Hsp90b1,P08113,Hsp90b1,1,551,86,84,P08113,MOUSE,92759.4,64,21,21.1,1394.27,1354.14,NA,802,Endoplasmin,extracellular region|nucleus|endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum membrane|cytosol|plasma membrane|focal adhesion|membrane|midbody|extracellular matrix|endoplasmic reticulum chaperone complex|melanosome|perinuclear region of cytoplasm|extracellular exosome|,"response to hypoxia|protein folding|ER-associated ubiquitin-dependent protein catabolic process|retrograde protein transport, ER to cytosol|actin rod assembly|negative regulation of apoptotic process|regulation of phosphoprotein phosphatase activity|cellular response to ATP|",RNA binding|protein binding|ATP binding|protein phosphatase binding|virion binding|low-density lipoprotein particle receptor binding|unfolded protein binding|,86,551,1.45E+12,64.00%
220,A11111,1.06E-05,-0.4925,72.14387661,2.615666667,6.10E-08,20.35749504,-1.997,-1.568,-1.836,0.683,0.829,0.934,A11111,NotFound,A11111_NotFound,A11111,A11111,1,241,39,39,A11111|P06709,MOUSE,39099.5,81.4,99,99.1,704.5,704.5,NA,NA,BirAG3ER,,,,39,241,8.91E+11,81.40%
520,P14211,1.78E-05,-0.2645,67.15154825,2.549,1.93E-07,17.46712003,-1.569,-1.536,-1.512,1.127,0.67,1.233,P14211,Calr,P14211_Calr,P14211,Calr,1,74,23,23,P14211,MOUSE,48164.8,54.5,304,304.1,332.61,332.61,NA,416,Calreticulin,acrosomal vesicle|extracellular region|extracellular space|nucleus|cytoplasm|endoplasmic reticulum|endoplasmic reticulum lumen|smooth endoplasmic reticulum|Golgi apparatus|cytosol|polysome|focal adhesion|external side of plasma membrane|membrane|extracellular matrix|sarcoplasmic reticulum lumen|MHC class I peptide loading complex|phagocytic vesicle|perinuclear region of cytoplasm|extracellular exosome|,"negative regulation of transcription from RNA polymerase II promoter|peptide antigen assembly with MHC class I protein complex|protein export from nucleus|cell cycle arrest|spermatogenesis|positive regulation of cell proliferation|positive regulation of gene expression|negative regulation of translation|cortical actin cytoskeleton organization|response to estradiol|negative regulation of intracellular steroid hormone receptor signaling pathway|response to testosterone|protein localization to nucleus|regulation of meiotic nuclear division|response to drug|negative regulation of neuron differentiation|positive regulation of DNA replication|positive regulation of cell cycle|negative regulation of transcription, DNA-templated|negative regulation of retinoic acid receptor signaling pathway|positive regulation of phagocytosis|protein stabilization|cardiac muscle cell differentiation|chaperone-mediated protein folding|cellular response to lithium ion|cellular response to organic substance|cellular senescence|positive regulation of substrate adhesion-dependent cell spreading|positive regulation of dendritic cell chemotaxis|",glycoprotein binding|mRNA binding|integrin binding|iron ion binding|calcium ion binding|protein binding|carbohydrate binding|ubiquitin protein ligase binding|peptide binding|hormone binding|poly(A) RNA binding|androgen receptor binding|unfolded protein binding|,23,74,3.88E+11,54.50%
96,P20029,1.31E-05,-0.243166667,69.25750542,2.539,1.19E-07,18.63468906,-1.627,-1.429,-1.482,1.091,0.747,1.241,P20029,Hspa5,P20029_Hspa5,P20029,Hspa5,1,509,70,67,P20029,MOUSE,72534.8,74.6,36,36.1,1124.65,1077.13,NA,655,78 kDa glucose-regulated protein,extracellular region|nucleus|mitochondrion|endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum membrane|smooth endoplasmic reticulum|endoplasmic reticulum-Golgi intermediate compartment|plasma membrane|focal adhesion|cell surface|membrane|integral component of endoplasmic reticulum membrane|midbody|endoplasmic reticulum chaperone complex|melanosome|myelin sheath|extracellular exosome|COP9 signalosome|,ER overload response|activation of signaling protein activity involved in unfolded protein response|cerebellum structural organization|cerebellar Purkinje cell layer development|substantia nigra development|positive regulation of cell migration|negative regulation of transforming growth factor beta receptor signaling pathway|positive regulation of protein ubiquitination|response to endoplasmic reticulum stress|maintenance of protein localization in endoplasmic reticulum|positive regulation of embryonic development|cellular response to glucose starvation|negative regulation of apoptotic process|proteolysis involved in cellular protein catabolic process|cellular response to antibiotic|cellular response to interleukin-4|toxin transport|,glycoprotein binding|protein binding|ATP binding|ATPase activity|enzyme binding|protein domain specific binding|ubiquitin protein ligase binding|ribosome binding|unfolded protein binding|misfolded protein binding|,70,509,1.73E+12,74.60%
3317,G5E8F8,0.000100198,-0.410666667,55.11849119,2.511333333,3.08E-06,12.32843109,-1.216,-2.006,-1.777,0.919,0.626,0.99,G5E8F8,Itgb5,G5E8F8_Itgb5,G5E8F8,Itgb5,1,2,2,2,G5E8F8|O70309-2|Q6PE70|O70309,MOUSE,93484.2,3.4,2865,2865.1,17.78,17.78,NA,816,Integrin beta,focal adhesion|cell surface|cell leading edge|integrin alphav-beta5 complex|receptor complex|extracellular exosome|,cell-matrix adhesion|transforming growth factor beta receptor signaling pathway|integrin-mediated signaling pathway|endodermal cell differentiation|stress fiber assembly|epithelial cell-cell adhesion|,receptor activity|integrin binding|,2,2,13900000,3.40%
559,O08795-2,1.06E-05,-0.371333333,77.58161462,2.484666667,1.75E-08,24.03182373,-1.661,-1.493,-1.687,0.976,0.718,0.919,O08795,Prkcsh,O08795-2_Prkcsh,O08795-2,Prkcsh,1,90,20,20,O08795-2|O08795,MOUSE,60528.5,36.1,329,329.1,315.58,315.58,NA,521,Isoform 2 of Glucosidase 2 subunit beta,endoplasmic reticulum|,in utero embryonic development|liver development|N-glycan processing|nitrogen compound metabolic process|negative regulation of neuron projection development|protein heterooligomerization|renal system development|,RNA binding|protein kinase C binding|calcium ion binding|protein binding|ion channel binding|phosphoprotein binding|,20,90,1.06E+11,36.10%
1126,Q9ERE7,1.06E-05,-0.342,71.64964673,2.446,6.84E-08,20.0519746,-1.728,-1.5,-1.467,1.034,0.679,0.93,Q9ERE7,Mesd,Q9ERE7_Mesd,Q9ERE7,Mesd,1,36,12,12,Q9ERE7,MOUSE,25320.3,45.5,750,750.1,169.29,169.29,NA,224,LRP chaperone MESD,endoplasmic reticulum|plasma membrane|,protein folding|mesoderm development|Wnt signaling pathway|protein localization to cell surface|,protein binding|low-density lipoprotein particle receptor binding|,12,36,1.33E+10,45.50%
1178,Q8BM72,1.06E-05,-0.378166667,71.7601399,2.445666667,6.67E-08,20.11989147,-1.672,-1.52,-1.611,1.095,0.712,0.727,Q8BM72,Hspa13,Q8BM72_Hspa13,Q8BM72,Hspa13,1,21,11,11,Q8BM72|D3Z0Y0|Q8BM72-2,MOUSE,51765.4,28.8,797,797.1,162.02,162.02,NA,471,Heat shock 70 kDa protein 13,endoplasmic reticulum|extracellular exosome|,,ATP binding|,11,21,5.17E+09,28.80%
178,Q8BMK4,1.06E-05,-0.2745,71.26521484,2.372333333,7.47E-08,19.81739783,-1.425,-1.506,-1.451,1.038,0.657,1.04,Q8BMK4,Ckap4,Q8BMK4_Ckap4,Q8BMK4,Ckap4,1,210,54,54,Q8BMK4,MOUSE,63748,74.7,76,76.1,788.6,788.6,NA,575,Cytoskeleton-associated protein 4,endoplasmic reticulum|endoplasmic reticulum membrane|lipid particle|cytoskeleton|plasma membrane|cell surface|integral component of membrane|perinuclear region of cytoplasm|extracellular exosome|,,poly(A) RNA binding|,54,210,1.40E+11,74.70%
202,P27773,3.68E-05,-0.194833333,61.57585156,2.367,6.96E-07,14.70297454,-1.439,-1.376,-1.32,1.076,0.617,1.273,P27773,Pdia3,P27773_Pdia3,P27773,Pdia3,1,204,46,46,P27773|P38657|A5D7E8,MOUSE,57133.7,68.7,89,89.1,719.19,719.19,NA,505,Protein disulfide-isomerase A3,nucleus|endoplasmic reticulum|endoplasmic reticulum lumen|smooth endoplasmic reticulum|focal adhesion|cell surface|melanosome|myelin sheath|extracellular exosome|,protein folding|response to endoplasmic reticulum stress|cell redox homeostasis|positive regulation of extrinsic apoptotic signaling pathway|,protein disulfide isomerase activity|protein binding|poly(A) RNA binding|,47,204,2.00E+11,68.70%
872,O35887,1.06E-05,-0.327333333,73.79131477,2.361333333,4.18E-08,21.40879947,-1.502,-1.426,-1.596,0.881,0.666,1.013,O35887,Calu,O35887_Calu,O35887,Calu,1,38,16,16,O35887|Q6XLQ8|G3V004|G3UWV3|G3UWR0,MOUSE,37177.2,50.1,540,540.1,223.84,223.84,NA,315,Calumenin,extracellular region|endoplasmic reticulum|endoplasmic reticulum lumen|membrane|sarcoplasmic reticulum lumen|melanosome|,peripheral nervous system axon regeneration|response to organic cyclic compound|negative regulation of catalytic activity|,enzyme inhibitor activity|calcium ion binding|enzyme binding|,16,38,1.55E+10,50.10%
445,B9EKR1,1.06E-05,-0.367,81.06107184,2.352666667,7.83E-09,26.71432187,-1.525,-1.528,-1.577,0.852,0.686,0.89,B9EKR1,Ptprz1,B9EKR1_Ptprz1,B9EKR1,Ptprz1,1,95,29,29,B9EKR1|B2RXS8|A0A0J9YVD2,MOUSE,255655.7,13,250,250.1,389.07,389.07,NA,2312,Receptor-type tyrosine-protein phosphatase zeta,proteinaceous extracellular matrix|plasma membrane|integral component of membrane|perineuronal net|,hematopoietic progenitor cell differentiation|axonogenesis|learning or memory|peptidyl-tyrosine dephosphorylation|oligodendrocyte differentiation|regulation of oligodendrocyte progenitor proliferation|,protein tyrosine phosphatase activity|protein binding|,29,95,6.17E+10,13.00%
1264,P57759,1.06E-05,-0.327,70.75425526,2.35,8.41E-08,19.50971364,-1.595,-1.458,-1.453,1.07,0.648,0.826,P57759,Erp29,P57759_Erp29,P57759,Erp29,1,33,12,12,P57759|D6RG87|F8WIM7|F8WJI4,MOUSE,28879.8,48.8,860,860.1,147.08,147.08,NA,262,Endoplasmic reticulum resident protein 29,endoplasmic reticulum|endoplasmic reticulum lumen|smooth endoplasmic reticulum|cell surface|membrane|transport vesicle|melanosome|extracellular exosome|,activation of MAPK activity|positive regulation of protein phosphorylation|ER to Golgi vesicle-mediated transport|protein secretion|positive regulation of gene expression|negative regulation of gene expression|negative regulation of protein secretion|regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway|,protein homodimerization activity|chaperone binding|,12,33,8.99E+09,48.80%
207,P09103,1.06E-05,-0.3015,72.86634862,2.346333333,5.17E-08,20.81222812,-1.535,-1.46,-1.429,0.938,0.652,1.025,P09103,P4hb,P09103_P4hb,P09103,P4hb,1,138,49,49,P09103|P05307|A6H7J6|E9Q8G8,MOUSE,57456.8,73.2,93,93.1,711.91,711.91,NA,509,Protein disulfide-isomerase,endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum-Golgi intermediate compartment|focal adhesion|external side of plasma membrane|procollagen-proline 4-dioxygenase complex|endoplasmic reticulum chaperone complex|melanosome|extracellular exosome|,protein folding|peptidyl-proline hydroxylation to 4-hydroxy-L-proline|response to endoplasmic reticulum stress|cell redox homeostasis|cellular response to hypoxia|regulation of oxidative stress-induced intrinsic apoptotic signaling pathway|,protein disulfide isomerase activity|integrin binding|protein binding|enzyme binding|poly(A) RNA binding|protein heterodimerization activity|procollagen-proline 4-dioxygenase activity|peptidyl-proline 4-dioxygenase activity|,49,138,5.54E+10,73.20%
237,P08003,2.15E-05,-0.181666667,65.11820175,2.344,3.08E-07,16.40641108,-1.394,-1.264,-1.403,1.109,0.669,1.193,P08003,Pdia4,P08003_Pdia4,P08003,Pdia4,1,155,45,44,A0A0R4J0Z1|P08003|F1MEN8|Q29RV1,MOUSE,72323.4,58.4,110,110.1,667.25,650.3,NA,638,Protein disulfide-isomerase A4,endoplasmic reticulum|endoplasmic reticulum lumen|cell surface|endoplasmic reticulum chaperone complex|melanosome|,protein folding|response to endoplasmic reticulum stress|cell redox homeostasis|chaperone-mediated protein folding|,protein disulfide isomerase activity|poly(A) RNA binding|,44,155,8.77E+10,56.80%
421,Q8BFZ9,0.018063217,0.454666667,27.9280416,2.314,0.001611372,4.811639624,-0.75,-0.753,-0.604,2.521,0.357,1.957,Q8BFZ9,Erlin2,Q8BFZ9_Erlin2,Q8BFZ9,Erlin2,1,148,27,23,Q8BFZ9,MOUSE,38100.1,60.2,234,234.1,412.76,356.23,NA,340,Erlin-2,cytoplasm|endoplasmic reticulum|endoplasmic reticulum membrane|plasma membrane|integral component of membrane|protein complex|membrane raft|extracellular exosome|,cholesterol metabolic process|ER-associated ubiquitin-dependent protein catabolic process|SREBP signaling pathway|negative regulation of cholesterol biosynthetic process|negative regulation of fatty acid biosynthetic process|,protein binding|ubiquitin protein ligase binding|,27,148,1.25E+11,60.20%
1053,Q80UU9,1.06E-05,-0.468,72.17937066,2.303333333,6.05E-08,20.37960901,-1.801,-1.639,-1.419,0.757,0.672,0.622,Q80UU9,Pgrmc2,Q80UU9_Pgrmc2,Q80UU9,Pgrmc2,1,34,14,12,Q80UU9,MOUSE,23447.8,47,689,689.1,182.62,158.97,NA,217,Membrane-associated progesterone receptor component 2,endomembrane system|membrane|integral component of membrane|,,steroid binding|heme binding|,14,34,2.69E+10,47.00%
1016,Q3TMX5,1.85E-05,-0.2155,66.50346419,2.299666667,2.24E-07,17.12213822,-1.423,-1.284,-1.389,1.074,0.637,1.092,Q3TMX5,Manf,Q3TMX5_Manf,Q3TMX5,Manf,1,54,15,15,Q3TMX5|Q80ZP8|Q9CXI5,MOUSE,20843.8,53,656,656.1,191.27,191.27,NA,179,"Arginine-rich, mutated in early stage tumors, isoform CRA_b",extracellular space|nucleus|endoplasmic reticulum|perinuclear region of cytoplasm|,vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure|,poly(A) RNA binding|,15,54,3.24E+10,53.00%
739,P55302,1.84E-05,-0.371833333,66.771325,2.281,2.10E-07,17.26392665,-1.758,-1.492,-1.287,0.863,0.645,0.798,P55302,Lrpap1,P55302_Lrpap1,P55302,Lrpap1,1,62,20,20,P55302,MOUSE,42214.3,46.3,437,437.1,262.25,262.25,NA,360,Alpha-2-macroglobulin receptor-associated protein,extracellular region|endoplasmic reticulum|plasma membrane|cell surface|vesicle|rough endoplasmic reticulum lumen|,negative regulation of very-low-density lipoprotein particle clearance|negative regulation of protein binding|extracellular negative regulation of signal transduction|negative regulation of beta-amyloid clearance|,heparin binding|lipase binding|receptor antagonist activity|low-density lipoprotein particle receptor binding|very-low-density lipoprotein particle receptor binding|,20,62,3.10E+10,46.30%
402,P35564,1.06E-05,-0.294333333,75.02941021,2.267333333,3.14E-08,22.23336673,-1.4,-1.403,-1.481,0.898,0.658,0.962,P35564,Canx,P35564_Canx,P35564,Canx,1,83,30,30,P35564,MOUSE,67676.1,56.1,222,222.1,427.85,427.85,NA,591,Calnexin,endoplasmic reticulum|endoplasmic reticulum membrane|smooth endoplasmic reticulum|rough endoplasmic reticulum|ribosome|membrane|integral component of membrane|axon|dendrite cytoplasm|melanosome|neuronal cell body|dendritic spine|myelin sheath|protein complex|ER-mitochondrion membrane contact site|extracellular exosome|integral component of lumenal side of endoplasmic reticulum membrane|,aging|synaptic vesicle endocytosis|chaperone-mediated protein folding|clathrin-mediated endocytosis|,glycoprotein binding|calcium ion binding|protein binding|carbohydrate binding|apolipoprotein binding|ionotropic glutamate receptor binding|poly(A) RNA binding|unfolded protein binding|,30,83,5.05E+10,56.10%
2667,P52194,0.000104533,-0.3435,54.73253977,2.255666667,3.36E-06,12.1764409,-1.05,-1.602,-1.762,0.696,0.699,0.958,P52194,Clgn,P52194_Clgn,P52194,Clgn,1,5,4,4,P52194,MOUSE,69886.2,7.3,2182,2182.1,35.3,35.3,NA,611,Calmegin,nuclear envelope|endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|,protein folding|protein complex assembly|multicellular organismal development|spermatogenesis|single fertilization|binding of sperm to zona pellucida|cell differentiation|meiotic cell cycle|,calcium ion binding|protein binding|protein binding involved in protein folding|unfolded protein binding|,4,5,2.66E+08,7.30%
73,Q8BI84,1.06E-05,-0.267166667,71.05691654,2.243,7.84E-08,19.69140562,-1.438,-1.348,-1.38,0.996,0.624,0.943,Q8BI84,Mia3,Q8BI84_Mia3,Q8BI84,Mia3,1,295,94,54,Q8BI84|Q8BI84-2|Q8BI84-3,MOUSE,214298.7,46.7,24,24.1,1340.15,812.65,NA,1930,Transport and Golgi organization protein 1 homolog,endoplasmic reticulum membrane|membrane|integral component of membrane|intracellular membrane-bounded organelle|,chondrocyte development|positive regulation of leukocyte migration|exocytosis|negative regulation of cell adhesion|protein transport|collagen fibril organization|negative regulation of cell migration|positive regulation of bone mineralization|wound healing|,,94,295,1.25E+11,46.70%
2672,Q6ZWQ7,2.28E-05,-0.2935,64.43377346,2.242333333,3.60E-07,16.06337937,-1.391,-1.606,-1.247,1.005,0.585,0.893,Q6ZWQ7,Spcs3,Q6ZWQ7_Spcs3,Q6ZWQ7,Spcs3,1,4,2,2,Q6ZWQ7,MOUSE,20370.1,11.6,2187,2187.1,34.95,34.95,NA,180,Signal peptidase complex subunit 3,endoplasmic reticulum|signal peptidase complex|integral component of membrane|,signal peptide processing|,peptidase activity|,2,4,1.92E+09,11.60%
2555,Q61335,0.000480539,-0.201,46.42655787,2.236666667,2.28E-05,9.287611384,-0.893,-1.504,-1.561,1.104,0.461,1.187,Q61335,Bcap31,Q61335_Bcap31,Q61335,Bcap31,1,7,4,4,Q61335,MOUSE,28013.1,17.9,2071,2071.1,39.42,39.42,NA,245,B-cell receptor-associated protein 31,Golgi membrane|mitochondrion|endoplasmic reticulum|lipid particle|cytosol|integral component of plasma membrane|membrane|clathrin-coated vesicle|Golgi cisterna membrane|endoplasmic reticulum-Golgi intermediate compartment membrane|Sec61 translocon complex|,"intracellular protein transport|ER to Golgi vesicle-mediated transport|positive regulation of cytosolic calcium ion concentration|spermatogenesis|negative regulation of endoplasmic reticulum calcium ion concentration|calcium-mediated signaling using intracellular calcium source|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of mitochondrial calcium ion concentration|protein localization to endoplasmic reticulum exit site|positive regulation of ER-associated ubiquitin-dependent protein catabolic process|positive regulation of retrograde protein transport, ER to cytosol|positive regulation of intrinsic apoptotic signaling pathway|",protein binding|protein complex binding|MHC class I protein binding|,4,7,1.84E+09,17.90%
2806,Q9CYA0,0.012038662,-0.275166667,30.01534433,2.202333333,0.000996473,5.217369477,-1.225,-2.413,-0.491,0.9,0.632,0.946,Q9CYA0,Creld2,Q9CYA0_Creld2,Q9CYA0,Creld2,1,4,4,4,Q9CYA0,MOUSE,40386.9,18.5,2319,2319.1,30.78,30.78,NA,350,Cysteine-rich with EGF-like domain protein 2,extracellular space|endoplasmic reticulum|Golgi apparatus|,,calcium ion binding|,4,4,4.06E+08,18.50%
1832,Q62177,3.63E-05,-0.235,61.81620981,2.150666667,6.58E-07,14.8130658,-1.202,-1.499,-1.23,0.884,0.572,1.065,Q62177,NotFound,Q62177_NotFound,Q62177,Sema3b,1,13,8,8,M9MMK0|Q62177|M0QWQ7|O08665,MOUSE,83839.7,10.6,1372,1372.1,81.09,81.09,NA,748,Semaphorin-3B,membrane|extracellular exosome|,nervous system development|cell differentiation|,,9,13,9.30E+08,10.60%
113,Q9JKR6,1.31E-05,-0.248833333,69.10773655,2.147,1.23E-07,18.54924054,-1.434,-1.275,-1.258,0.983,0.616,0.875,Q9JKR6,Hyou1,Q9JKR6_Hyou1,Q9JKR6,Hyou1,1,309,70,70,Q9JKR6|E0CYZ2,MOUSE,111407.3,63.9,43,43.1,1075.73,1075.73,NA,999,Hypoxia up-regulated protein 1,extracellular region|endoplasmic reticulum lumen|focal adhesion|membrane|endoplasmic reticulum chaperone complex|extracellular exosome|,response to ischemia|response to endoplasmic reticulum stress|negative regulation of apoptotic process|cellular response to hypoxia|negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway|negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway|,ATP binding|,70,309,2.98E+11,63.90%
2520,Q31125,0.002832067,0.2335,37.07047213,2.124333333,0.000196315,6.752581656,-0.911,-0.693,-0.882,1.649,0.473,1.765,Q31125,Slc39a7,Q31125_Slc39a7,Q31125,Slc39a7,1,5,3,3,Q31125,MOUSE,50826.8,11.3,2037,2037.1,40.87,40.87,NA,476,Zinc transporter SLC39A7,nucleoplasm|endoplasmic reticulum|endoplasmic reticulum membrane|Golgi apparatus|integral component of membrane|,zinc II ion transport|transmembrane transport|,protein binding|metal ion transmembrane transporter activity|,3,5,1.85E+08,11.30%
3356,A2A7A7,0.000209993,-0.351333333,50.94424002,2.116,8.05E-06,10.77236835,-1.167,-1.887,-1.174,0.795,0.567,0.758,A2A7A7,H6pd,A2A7A7_H6pd,A2A7A7,H6pd,1,3,2,2,A2A7A7|Q8CF,MOUSE,90478.8,3,2910,2910.1,17.15,17.15,NA,797,GDH/6PGL endoplasmic bifunctional protein,mitochondrion|,glucose metabolic process|pentose-phosphate shunt|oxidation-reduction process|response to alcohol|,glucose-6-phosphate dehydrogenase activity|6-phosphogluconolactonase activity|carbohydrate binding|NADP binding|,2,3,68300000,3.00%
1980,Q61334,0.000121745,-0.171833333,53.76888471,2.105,4.20E-06,11.80438821,-1.185,-0.987,-1.501,1.09,0.557,0.995,Q61334,Bcap29,Q61334_Bcap29,Q61334,Bcap29,1,12,5,5,Q61334,MOUSE,28020.4,16.2,1508,1508.1,69.63,69.63,NA,240,B-cell receptor-associated protein 29,endoplasmic reticulum membrane|membrane|integral component of membrane|,osteoblast differentiation|intracellular protein transport|ER to Golgi vesicle-mediated transport|apoptotic process|protein localization to endoplasmic reticulum exit site|,,5,12,1.93E+09,16.20%
2645,Q99KI3,0.000881855,0.091,43.00700332,2.095333333,5.00E-05,8.284191473,-1.015,-0.953,-0.902,1.469,0.48,1.467,Q99KI3,Emc3,Q99KI3_Emc3,Q99KI3,Emc3,1,6,4,4,Q99KI3,MOUSE,29979.5,9.1,2161,2161.1,36.33,36.33,NA,261,ER membrane protein complex subunit 3,integral component of membrane|ER membrane protein complex|,protein folding in endoplasmic reticulum|,,4,6,1.37E+09,9.10%
1169,Q05186,1.31E-05,-0.300666667,69.1050132,2.086666667,1.23E-07,18.54769027,-1.478,-1.277,-1.277,0.918,0.59,0.72,Q05186,Rcn1,Q05186_Rcn1,Q05186,Rcn1,1,35,12,12,Q05186,MOUSE,38112.4,42.4,789,789.1,164.59,164.59,NA,325,Reticulocalbin-1,endoplasmic reticulum|endoplasmic reticulum lumen|,in utero embryonic development|camera-type eye development|,calcium ion binding|,12,35,1.12E+10,42.40%
1881,Q9D1D4,5.43E-05,-0.147666667,58.64946225,2.068,1.36E-06,13.42255651,-1.33,-1.126,-1.089,0.969,0.558,1.132,Q9D1D4,Tmed10,Q9D1D4_Tmed10,Q9D1D4,Tmed10,1,21,6,6,Q9D1D4|A0A1Y7VM54|Q9D1D4-2,MOUSE,25081.5,33.3,1417,1417.1,77.35,77.35,NA,219,Transmembrane emp24 domain-containing protein 10,Golgi membrane|endoplasmic reticulum|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|cis-Golgi network|plasma membrane|integral component of membrane|COPI-coated vesicle|trans-Golgi network transport vesicle|transport vesicle membrane|secretory granule membrane|endoplasmic reticulum-Golgi intermediate compartment membrane|melanosome|zymogen granule membrane|extracellular exosome|gamma-secretase complex|,"kidney development|intracellular protein transport|retrograde vesicle-mediated transport, Golgi to ER|Golgi organization|COPI-coated vesicle budding|response to alkaloid|regulated secretory pathway|vesicle targeting, to, from or within Golgi|protein oligomerization|regulation of beta-amyloid formation|",syntaxin binding|protein complex binding|,6,21,2.73E+09,33.30%
2084,Q99KF1,0.000118594,-0.171833333,53.95379468,2.063666667,4.02E-06,11.81948973,-1.47,-1.117,-1.024,0.957,0.531,1.092,Q99KF1,Tmed9,Q99KF1_Tmed9,Q99KF1,Tmed9,1,10,5,4,Q99KF1|A0A286YDS5,MOUSE,27240.8,18.2,1607,1607.1,61.8,46.99,NA,235,Transmembrane emp24 domain-containing protein 9,Golgi membrane|endoplasmic reticulum|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|integral component of membrane|endoplasmic reticulum-Golgi intermediate compartment membrane|extracellular exosome|,Golgi organization|positive regulation of organelle organization|protein transport|COPI coating of Golgi vesicle|,syntaxin binding|,5,10,3.60E+08,18.20%
2705,Q7TQN3,0.000627114,-0.0175,44.9104007,2.055666667,3.23E-05,8.830767879,-1.295,-0.96,-0.881,1.19,0.472,1.369,Q7TQN3,Wfikkn2,Q7TQN3_Wfikkn2,Q7TQN3,Wfikkn2,1,5,3,3,Q7TQN3,MOUSE,65557.4,5.6,2219,2219.1,34.07,34.07,NA,571,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",extracellular region|,skeletal system development|transforming growth factor beta receptor signaling pathway|negative regulation of endopeptidase activity|negative regulation of protein binding|negative regulation of DNA binding|muscle fiber development|palate development|,serine-type endopeptidase inhibitor activity|protein binding|metalloendopeptidase inhibitor activity|,3,5,2.63E+08,5.60%
1629,A0A0R4J0I1,2.12E-05,-0.423666667,65.54835243,2.046,2.79E-07,16.62555036,-1.56,-1.2,-1.58,0.528,0.709,0.561,A0A0R4J0I1,Serpina3k,A0A0R4J0I1_Serpina3k,A0A0R4J0I1,Serpina3k,1,12,8,8,A0A0R4J0I1|P07759|Q03734|Q5I2A0|G3X8T9|P29621|Q91WP6|F2Z405,MOUSE,46900.1,30.8,1186,1186.1,101.38,101.38,NA,418,MCG1051009,,,,8,12,3.08E+08,30.80%
1261,P24668,0.00023927,-0.190666667,50.31158759,2.043333333,9.31E-06,10.55262257,-1.615,-1.062,-0.96,0.94,0.56,0.993,P24668,M6pr,P24668_M6pr,P24668,M6pr,1,23,10,10,P24668,MOUSE,31685.3,33.8,857,857.1,147.24,147.24,NA,278,Cation-dependent mannose-6-phosphate receptor,lysosomal membrane|endosome|late endosome|membrane|integral component of membrane|perinuclear region of cytoplasm|,intracellular protein transport|mannose transport|,mannose transmembrane transporter activity|,10,23,7.11E+09,33.80%
1940,Q8BPB5,2.47E-05,-0.194333333,63.84566283,2.041333333,4.13E-07,15.7740668,-1.23,-1.1,-1.315,0.835,0.593,1.051,Q8BPB5,Efemp1,Q8BPB5_Efemp1,Q8BPB5,Efemp1,1,11,7,7,Q8BPB5,MOUSE,57234.1,16.4,1471,1471.1,73.03,73.03,NA,493,EGF-containing fibulin-like extracellular matrix protein 1,proteinaceous extracellular matrix|extracellular space|extracellular exosome|extracellular matrix|,"regulation of transcription, DNA-templated|epidermal growth factor receptor signaling pathway|peptidyl-tyrosine phosphorylation|negative regulation of chondrocyte differentiation|",epidermal growth factor-activated receptor activity|epidermal growth factor receptor binding|calcium ion binding|growth factor activity|,7,11,7.45E+08,16.40%
3299,G5E8Q0,1.06E-05,-0.337,75.32357572,2.041333333,2.94E-08,22.43377321,-1.41,-1.36,-1.303,0.72,0.557,0.774,G5E8Q0,Lyst,G5E8Q0_Lyst,G5E8Q0,Lyst,1,4,2,2,G5E8Q0|P97412,MOUSE,430850.7,0.4,2845,2845.1,18.12,18.12,NA,3787,"Lysosomal trafficking regulator, isoform CRA_a",cytosol|endomembrane system|microtubule cytoskeleton|extrinsic component of membrane|,neutrophil mediated immunity|T cell mediated immunity|phospholipid metabolic process|microtubule-based process|lysosome organization|blood coagulation|endosomal transport|leukocyte chemotaxis|melanosome organization|endosome to lysosome transport via multivesicular body sorting pathway|positive regulation of natural killer cell activation|secretion of lysosomal enzymes|mast cell secretory granule organization|natural killer cell mediated cytotoxicity|response to drug|defense response to bacterium|defense response to protozoan|pigmentation|pigment granule organization|defense response to virus|phospholipid homeostasis|,phospholipid binding|,2,4,9.06E+08,0.40%
1757,P09470,0.000123671,-0.270666667,53.6608257,1.995333333,4.30E-06,11.62261682,-1.172,-1.501,-1.132,0.545,0.553,1.083,P09470,Ace,P09470_Ace,P09470,Ace,1,9,7,7,P09470|P09470-2,MOUSE,151771.2,7,1299,1299.1,89.28,89.28,NA,1312,Angiotensin-converting enzyme,extracellular space|cytoplasm|lysosome|endosome|plasma membrane|external side of plasma membrane|integral component of membrane|extracellular exosome|,kidney development|neutrophil mediated immunity|regulation of systemic arterial blood pressure by renin-angiotensin|positive regulation of systemic arterial blood pressure|proteolysis|spermatogenesis|regulation of blood pressure|posttranscriptional regulation of gene expression|negative regulation of gene expression|negative regulation of protein binding|positive regulation of protein binding|hormone catabolic process|peptide catabolic process|beta-amyloid metabolic process|arachidonic acid secretion|heart contraction|regulation of angiotensin metabolic process|positive regulation of protein tyrosine kinase activity|cell proliferation in bone marrow|positive regulation of peptidyl-tyrosine autophosphorylation|regulation of hematopoietic stem cell proliferation|negative regulation of gap junction assembly|positive regulation of peptidyl-cysteine S-nitrosylation|,actin binding|endopeptidase activity|carboxypeptidase activity|protein binding|drug binding|peptidase activity|metallopeptidase activity|exopeptidase activity|tripeptidyl-peptidase activity|peptidyl-dipeptidase activity|zinc ion binding|chloride ion binding|mitogen-activated protein kinase kinase binding|bradykinin receptor binding|mitogen-activated protein kinase binding|,7,9,9.78E+08,7.00%
424,Q8R180,1.06E-05,-0.336,75.04650463,1.993333333,3.13E-08,22.24496485,-1.449,-1.221,-1.328,0.681,0.621,0.68,Q8R180,Ero1l,Q8R180_Ero1l,Q8R180,Ero1a,1,89,30,30,Q8R180|A0A1Y7VJM4|Q8R2E9|A0A1Y7VNF4,MOUSE,54939.2,67,236,236.1,411.62,411.62,NA,464,ERO1-like protein alpha,endoplasmic reticulum|membrane|integral component of endoplasmic reticulum membrane|,protein folding|4-hydroxyproline metabolic process|protein maturation by protein folding|extracellular matrix organization|endoplasmic reticulum unfolded protein response|response to endoplasmic reticulum stress|cell redox homeostasis|brown fat cell differentiation|chaperone mediated protein folding requiring cofactor|release of sequestered calcium ion into cytosol|oxidation-reduction process|intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress|,"protein disulfide isomerase activity|protein disulfide oxidoreductase activity|oxidoreductase activity|oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor|",32,89,4.58E+10,67.00%
2085,Q8R1V4,0.000250687,-0.1325,49.9488831,1.967666667,1.01E-05,10.42844499,-0.78,-1.425,-1.144,0.982,0.558,1.014,Q8R1V4,Tmed4,Q8R1V4_Tmed4,Q8R1V4,Tmed4,1,3,4,3,Q8R1V4,MOUSE,26249.7,14.9,1607,1607.2,57,42.19,NA,227,Transmembrane emp24 domain-containing protein 4,endoplasmic reticulum membrane|integral component of membrane|extracellular exosome|,signal transduction|protein transport|positive regulation of I-kappaB kinase/NF-kappaB signaling|,signal transducer activity|,3,3,3.47E+08,7.40%
1526,Q9DAU1,1.06E-05,-0.246333333,71.80256361,1.962,6.60E-08,20.14602711,-1.271,-1.192,-1.219,0.865,0.579,0.76,Q9DAU1,Cnpy3,Q9DAU1_Cnpy3,Q9DAU1,Cnpy3,1,17,7,7,Q9DAU1|Q9DAU1-2|B0V2V1,MOUSE,30936.7,29.3,1095,1095.1,111.6,111.6,NA,276,Protein canopy homolog 3,endoplasmic reticulum|,innate immune response|,receptor binding|,7,17,4.04E+09,29.30%
281,Q9R1E6-3,0.000149302,-0.055166667,52.52622413,1.944333333,5.59E-06,11.22969815,-1.113,-1.021,-0.948,0.951,0.538,1.262,Q9R1E6,Enpp2,Q9R1E6-3_Enpp2,Q9R1E6-3,Enpp2,1,139,41,41,Q9R1E6-3|Q9R1E6|Q9R1E6-2|G3UXY9,MOUSE,103560.5,43.6,135,135.1,584.76,584.76,NA,862,Isoform 3 of Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,extracellular space|integral component of plasma membrane|,receptor-mediated endocytosis|chemotaxis|immune response|phospholipid catabolic process|positive regulation of epithelial cell migration|regulation of cell migration|phosphatidylcholine catabolic process|regulation of angiogenesis|positive regulation of peptidyl-tyrosine phosphorylation|nucleic acid phosphodiester bond hydrolysis|positive regulation of lamellipodium morphogenesis|,nucleic acid binding|phosphodiesterase I activity|nucleotide diphosphatase activity|lysophospholipase activity|scavenger receptor activity|calcium ion binding|zinc ion binding|polysaccharide binding|alkylglycerophosphoethanolamine phosphodiesterase activity|,41,139,1.02E+11,43.60%
1908,Q9ERR7,1.06E-05,-0.337166667,77.32268574,1.924333333,1.85E-08,23.84308584,-1.331,-1.32,-1.247,0.69,0.577,0.608,Q9ERR7,Selenof,Q9ERR7_Selenof,Q9ERR7,Selenof,1,14,6,6,Q9ERR7|A0A0R4J0K1|A0A1C7ZMY4,MOUSE,18191.8,51.2,1442,1442.1,75.3,75.3,NA,162,Selenoprotein F,endoplasmic reticulum lumen|extracellular exosome|,'de novo' posttranslational protein folding|,protein binding|selenium binding|,6,14,5.14E+09,51.20%
459,E9PY90,2.18E-05,-0.185333333,64.88627549,1.909333333,3.25E-07,16.2893991,-1.184,-1.164,-1.072,0.953,0.543,0.812,E9PY90,Mia2,E9PY90_Mia2,E9PY90,Mia2,1,58,29,1,E9PY90|H3BK44|H3BKL6,MOUSE,87013.3,47.4,261,261.1,377.47,18.35,NA,772,Melanoma inhibitory activity protein 2,membrane|,,,29,58,1.50E+10,47.40%
2643,Q8K007,5.44E-05,-0.195166667,58.44312066,1.886333333,1.43E-06,13.33631111,-1.092,-1.297,-1.026,0.704,0.522,1.018,Q8K007,Sulf1,Q8K007_Sulf1,Q8K007,Sulf1,1,4,4,4,Q8K007|A0A0R4J2D2,MOUSE,102233.1,4.5,2159,2159.1,36.38,36.38,NA,870,Extracellular sulfatase Sulf-1,extracellular space|endoplasmic reticulum|Golgi apparatus|Golgi stack|plasma membrane|cell surface|membrane raft|,cartilage condensation|kidney development|negative regulation of endothelial cell proliferation|chondrocyte development|glomerular filtration|sulfur compound metabolic process|apoptotic process|cell adhesion|positive regulation of vascular endothelial growth factor production|esophagus smooth muscle contraction|negative regulation of angiogenesis|positive regulation of Wnt signaling pathway|heparan sulfate proteoglycan metabolic process|negative regulation of cell migration|positive regulation of BMP signaling pathway|glomerular basement membrane development|glial cell-derived neurotrophic factor receptor signaling pathway|limb joint morphogenesis|regulation of fibroblast growth factor receptor signaling pathway|negative regulation of fibroblast growth factor receptor signaling pathway|vascular endothelial growth factor receptor signaling pathway|positive regulation of smooth muscle cell proliferation|embryonic skeletal system development|cartilage development|bone development|innervation|negative regulation of prostatic bud formation|,arylsulfatase activity|calcium ion binding|N-acetylglucosamine-6-sulfatase activity|,4,4,8.30E+07,4.50%
3377,Q9Z1T2,0.001077727,-0.263666667,42.00360412,1.884,6.30E-05,8.007535283,-1.448,-1.222,-0.947,0.312,0.52,1.203,Q9Z1T2,Thbs4,Q9Z1T2_Thbs4,Q9Z1T2,Thbs4,1,2,2,2,Q9Z1T2,MOUSE,109046.1,3,2936,2936.1,16.65,16.65,NA,963,Thrombospondin-4,basement membrane|extracellular space|endoplasmic reticulum|sarcoplasmic reticulum|extracellular matrix|extracellular exosome|,positive regulation of endothelial cell proliferation|response to unfolded protein|negative regulation of angiogenesis|regulation of tissue remodeling|response to endoplasmic reticulum stress|behavioral response to pain|tissue remodeling|positive regulation of peptidyl-tyrosine phosphorylation|myoblast migration|positive regulation of cell division|endothelial cell-cell adhesion|positive regulation of neutrophil chemotaxis|,integrin binding|calcium ion binding|protein binding|growth factor activity|heparin binding|,2,2,11600000,3.00%
1335,P18242,3.68E-05,-0.206,61.52059465,1.87,7.05E-07,14.67777408,-1.059,-1.296,-1.068,0.689,0.544,0.954,P18242,Ctsd,P18242_Ctsd,P18242,Ctsd,1,30,9,9,P18242|F8WIR1,MOUSE,45409.4,27.8,924,924.1,137.47,137.47,NA,410,Cathepsin D,extracellular space|mitochondrion|lysosome|melanosome|membrane raft|extracellular exosome|extracellular matrix|,autophagosome assembly|proteolysis|autophagy|protein catabolic process|epithelial tube branching involved in lung morphogenesis|,aspartic-type endopeptidase activity|peptidase activity|peptide binding|,9,30,8.74E+09,27.80%
1616,Q80W54,2.15E-05,-0.194833333,65.24593859,1.867666667,2.99E-07,16.47119788,-1.13,-1.214,-1.042,0.93,0.559,0.728,Q80W54,Zmpste24,Q80W54_Zmpste24,Q80W54,Zmpste24,1,23,7,7,Q80W54,MOUSE,55018.7,19.1,1173,1173.1,103.64,103.64,NA,475,CAAX prenyl protease 1 homolog,nuclear inner membrane|endoplasmic reticulum membrane|membrane|integral component of membrane|extracellular exosome|,nuclear envelope organization|prenylated protein catabolic process|CAAX-box protein processing|,metalloendopeptidase activity|metal ion binding|,7,23,6.66E+09,19.10%
302,Q91YW3,4.30E-05,-0.121666667,60.43146197,1.863333333,9.05E-07,14.18925211,-1.147,-0.983,-1.03,0.863,0.543,1.024,Q91YW3,Dnajc3,Q91YW3_Dnajc3,Q91YW3,Dnajc3,1,126,41,41,Q91YW3,MOUSE,57919.4,68.6,151,151.1,552.26,552.26,NA,504,DnaJ homolog subfamily C member 3,cytoplasm|endoplasmic reticulum lumen|smooth endoplasmic reticulum|cytosol|membrane|extracellular exosome|extracellular vesicle|endoplasmic reticulum Sec complex|,negative regulation of protein kinase activity|endoplasmic reticulum unfolded protein response|negative regulation of apoptotic process|proteolysis involved in cellular protein catabolic process|negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation|negative regulation of cyclin-dependent protein kinase activity|,protein binding|chaperone binding|misfolded protein binding|,41,126,1.07E+11,68.60%
1020,Q922Q9,1.06E-05,-0.289333333,71.25326836,1.846666667,7.49E-08,19.81015084,-1.108,-1.356,-1.174,0.672,0.595,0.635,Q922Q9,Chid1,Q922Q9_Chid1,Q922Q9,Chid1,1,33,12,12,A0A0R4J242|Q922Q9|A0A0R4J058|Q922Q9-2|A0A1B0GSH5,MOUSE,45075.9,35.1,660,660.1,189.2,189.2,NA,393,Chitinase domain-containing protein 1,extracellular region|extracellular space|nucleus|lysosome|late endosome|trans-Golgi network|membrane|extracellular exosome|,carbohydrate metabolic process|chitin catabolic process|innate immune response|negative regulation of cytokine production involved in inflammatory response|,chitinase activity|chitin binding|oligosaccharide binding|,12,33,5.32E+09,35.10%
604,Q8C341-2,1.06E-05,-0.292666667,77.21447421,1.843333333,1.90E-08,23.76463798,-1.236,-1.221,-1.186,0.628,0.585,0.674,Q8C341,Suco,Q8C341-2_Suco,Q8C341-2,Suco,1,40,23,23,Q8C341-2|Q8C341,MOUSE,140779.6,22.2,352,352.1,301.39,301.39,NA,1250,Isoform 2 of SUN domain-containing ossification factor,rough endoplasmic reticulum|membrane|integral component of membrane|rough endoplasmic reticulum membrane|,multicellular organismal development|positive regulation of collagen biosynthetic process|positive regulation of osteoblast differentiation|regulation of bone remodeling|,,23,40,2.38E+09,22.20%
972,Q03517,0.001080735,-0.027666667,41.9698367,1.831333333,6.35E-05,7.998358152,-0.917,-0.964,-0.949,1.398,0.894,0.372,Q03517,Scg2,Q03517_Scg2,Q03517,Scg2,1,39,15,15,Q03517|Q4W8U9,MOUSE,70642.7,30.3,624,624.1,199.64,199.64,NA,617,Secretogranin-2,extracellular space|secretory granule|,MAPK cascade|angiogenesis|positive regulation of endothelial cell proliferation|intracellular signal transduction|eosinophil chemotaxis|positive chemotaxis|induction of positive chemotaxis|negative regulation of endothelial cell apoptotic process|negative regulation of extrinsic apoptotic signaling pathway|,cytokine activity|chemoattractant activity|,15,39,4.70E+09,30.30%
124,Q6P5E4,1.06E-05,-0.236333333,72.177555,1.824666667,6.06E-08,20.37847724,-1.228,-1.131,-1.087,0.743,0.568,0.717,Q6P5E4,Uggt1,Q6P5E4_Uggt1,Q6P5E4,Uggt1,1,211,71,71,Q6P5E4|G3UZU8,MOUSE,177115,49.5,49,49.1,1024.32,1024.32,NA,1551,UDP-glucose:glycoprotein glucosyltransferase 1,endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum-Golgi intermediate compartment|extracellular exosome|,protein glycosylation|UDP-glucosylation|,UDP-glucose:glycoprotein glucosyltransferase activity|protein binding|unfolded protein binding|,71,211,7.59E+10,49.50%
1294,Q9D0F3,0.001911789,0.082166667,39.04154212,1.813,0.000124694,7.234012066,-1.091,-0.739,-0.643,1.304,0.393,1.269,Q9D0F3,Lman1,Q9D0F3_Lman1,Q9D0F3,Lman1,1,34,11,11,Q9D0F3,MOUSE,58073,27,887,887.1,142.52,142.52,NA,517,Protein ERGIC-53,Golgi membrane|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|membrane|integral component of membrane|sarcomere|ER to Golgi transport vesicle|endoplasmic reticulum-Golgi intermediate compartment membrane|host cell perinuclear region of cytoplasm|extracellular exosome|,ER to Golgi vesicle-mediated transport|endoplasmic reticulum organization|Golgi organization|positive regulation of organelle organization|protein transport|,carbohydrate binding|metal ion binding|,11,34,7.94E+09,27.00%
1695,Q8VHI3,0.000245611,-0.271666667,50.0693114,1.811333333,9.84E-06,10.40675559,-0.764,-1.393,-1.375,0.757,0.598,0.547,Q8VHI3,Pofut2,Q8VHI3_Pofut2,Q8VHI3,Pofut2,1,16,8,8,Q8VHI3,MOUSE,49770.7,18.1,1244,1244.1,95.03,95.03,NA,429,GDP-fucose protein O-fucosyltransferase 2,endoplasmic reticulum|Golgi apparatus|,mesoderm formation|fucose metabolic process|regulation of gene expression|regulation of epithelial to mesenchymal transition|fucosylation|protein O-linked fucosylation|regulation of secretion|,fucosyltransferase activity|peptide-O-fucosyltransferase activity|,8,16,8.27E+08,18.10%
411,Q02819,1.06E-05,-0.281666667,71.92254421,1.806666667,6.42E-08,20.22012041,-1.287,-1.186,-1.082,0.673,0.558,0.634,Q02819,Nucb1,Q02819_Nucb1,Q02819,Nucb1,1,69,28,28,Q02819|A0A1C7CYU3,MOUSE,53407.7,63.8,227,227.1,421.43,421.43,NA,459,Nucleobindin-1,extracellular space|nucleus|early endosome|rough endoplasmic reticulum|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|Golgi-associated vesicle|cis-Golgi network|trans-Golgi network|microtubule cytoskeleton|membrane|Golgi cisterna membrane|extracellular exosome|extrinsic component of Golgi membrane|lumenal side of Golgi membrane|,response to cisplatin|regulation of protein targeting|,G-protein alpha-subunit binding|DNA binding|calcium ion binding|,28,69,3.88E+10,63.80%
1045,P09055,2.08E-05,-0.216666667,65.82701789,1.789333333,2.61E-07,16.76899957,-1.13,-0.944,-1.26,0.655,0.601,0.778,P09055,Itgb1,P09055_Itgb1,P09055,Itgb1,1,22,14,14,P09055|P09055-2|Q9Z0T9|B1AYG6,MOUSE,91481.9,19.6,683,683.1,184.78,184.78,NA,798,Integrin beta-1,cytoplasm|plasma membrane|focal adhesion|external side of plasma membrane|cell surface|intercalated disc|membrane|lamellipodium|filopodium|neuromuscular junction|integrin alpha1-beta1 complex|integrin alpha2-beta1 complex|integrin alpha3-beta1 complex|integrin alpha7-beta1 complex|integrin alpha10-beta1 complex|integrin alpha11-beta1 complex|myelin sheath abaxonal region|sarcolemma|melanosome|dendritic spine|receptor complex|membrane raft|synapse|recycling endosome|extracellular exosome|invadopodium membrane|synaptic membrane|plasma membrane|cytoplasmic vesicle|ruffle membrane|perinuclear region of cytoplasm|,G1/S transition of mitotic cell cycle|in utero embryonic development|cell fate specification|cell migration involved in sprouting angiogenesis|leukocyte cell-cell adhesion|cell-matrix adhesion|calcium-independent cell-matrix adhesion|integrin-mediated signaling pathway|positive regulation of cell proliferation|germ cell migration|visual learning|regulation of collagen catabolic process|cell migration|formation of radial glial scaffolds|neuron projection development|cell-substrate adhesion|cell-cell adhesion mediated by integrin|heterotypic cell-cell adhesion|negative regulation of Rho protein signal transduction|positive regulation of apoptotic process|sarcomere organization|negative regulation of cell differentiation|mesodermal cell differentiation|axon extension|cardiac muscle tissue development|dendrite morphogenesis|leukocyte tethering or rolling|regulation of cell cycle|cardiac muscle cell differentiation|positive regulation of establishment of protein localization to plasma membrane|negative regulation of anoikis|transforming growth factor beta receptor signaling pathway|stress fiber assembly|,fibronectin binding|protease binding|actin binding|receptor activity|integrin binding|protein binding|metal ion binding|protein heterodimerization activity|cell adhesion molecule binding|collagen binding involved in cell-matrix adhesion|laminin binding|,14,22,1.59E+09,19.60%
2037,P15208,5.01E-05,-0.177833333,59.36282668,1.766333333,1.16E-06,13.72472787,-1.096,-1.161,-0.926,0.698,0.489,0.929,P15208,Insr,P15208_Insr,P15208,Insr,1,3,5,3,P15208,MOUSE,158288.9,4,1561,1561.2,49.07,28.39,NA,1372,Insulin receptor,plasma membrane|integral component of plasma membrane|insulin receptor complex|caveola|membrane|intracellular membrane-bounded organelle|receptor complex|extracellular exosome|,"activation of MAPK activity|positive regulation of protein phosphorylation|heart morphogenesis|regulation of transcription, DNA-templated|G-protein coupled receptor signaling pathway|positive regulation of cell proliferation|insulin receptor signaling pathway|epidermis development|male gonad development|organ morphogenesis|peptidyl-tyrosine phosphorylation|transformation of host cell by virus|signal transduction by protein phosphorylation|male sex determination|adrenal gland development|positive regulation of cell migration|exocrine pancreas development|activation of protein kinase activity|activation of protein kinase B activity|cellular response to insulin stimulus|peptidyl-tyrosine autophosphorylation|glucose homeostasis|positive regulation of MAPK cascade|positive regulation of nitric oxide biosynthetic process|positive regulation of glycogen biosynthetic process|positive regulation of DNA replication|positive regulation of glycolytic process|positive regulation of mitotic nuclear division|positive regulation of transcription, DNA-templated|regulation of embryonic development|positive regulation of glucose import|protein autophosphorylation|positive regulation of developmental growth|protein heterotetramerization|positive regulation of meiotic cell cycle|positive regulation of protein kinase B signaling|positive regulation of respiratory burst|cellular response to growth factor stimulus|regulation of female gonad development|",protein tyrosine kinase activity|receptor signaling protein tyrosine kinase activity|insulin-activated receptor activity|insulin-like growth factor receptor binding|protein binding|ATP binding|GTP binding|insulin-like growth factor I binding|insulin-like growth factor II binding|phosphatidylinositol 3-kinase binding|insulin binding|insulin receptor substrate binding|PTB domain binding|,3,3,67700000,2.60%
1163,Q8BYB9,1.06E-05,-0.338166667,72.9862746,1.761,5.03E-08,20.88865697,-1.201,-1.28,-1.175,0.454,0.594,0.579,Q8BYB9,Poglut1,Q8BYB9_Poglut1,Q8BYB9,Poglut1,1,27,13,13,Q8BYB9,MOUSE,46892.1,29.8,784,784.1,165.65,165.65,NA,392,Protein O-glucosyltransferase 1,endoplasmic reticulum lumen|extracellular exosome|,protein O-linked glycosylation|regulation of Notch signaling pathway|cardiovascular system development|,protein xylosyltransferase activity|UDP-glucosyltransferase activity|UDP-xylosyltransferase activity|glucosyltransferase activity|,13,27,4.12E+09,29.80%
3210,Q9EPS3,2.64E-05,-0.154,63.42001257,1.760666667,4.55E-07,15.56775928,-1.136,-0.919,-1.048,0.845,0.529,0.805,Q9EPS3,Glce,Q9EPS3_Glce,Q9EPS3,Glce,1,5,3,3,Q9EPS3,MOUSE,70429.9,5.3,2738,2738.1,20.07,20.07,NA,618,D-glucuronyl C5-epimerase,Golgi membrane|Golgi apparatus|integral component of membrane|,heparan sulfate proteoglycan biosynthetic process|heparin biosynthetic process|,"racemase and epimerase activity, acting on carbohydrates and derivatives|heparosan-N-sulfate-glucuronate 5-epimerase activity|UDP-glucuronate 5'-epimerase activity|",3,5,3.29E+08,5.30%
3216,P62342,5.36E-05,-0.253166667,58.80314431,1.759666667,1.32E-06,13.48712726,-0.997,-1.371,-1.031,0.799,0.513,0.568,P62342,Selenot,P62342_Selenot,P62342,Selenot,1,2,2,2,P62342,MOUSE,22449.2,10.2,2744,2744.1,19.92,19.92,NA,195,Thioredoxin reductase-like selenoprotein T,endoplasmic reticulum|,response to glucose|pancreas development|insulin secretion involved in cellular response to glucose stimulus|glucose homeostasis|cell redox homeostasis|,selenium binding|,2,2,6.43E+08,10.20%
410,Q8C7X2,0.000136405,0.003,53.0564738,1.758666667,4.95E-06,11.25704028,-0.888,-0.835,-0.906,1.077,0.505,1.065,Q8C7X2,Emc1,Q8C7X2_Emc1,Q8C7X2,Emc1,1,85,30,30,Q8C7X2|Z4YJW0|Q8C7X2-2|Q8C7X2-3,MOUSE,112002.5,37.3,226,226.1,422.2,422.2,NA,997,ER membrane protein complex subunit 1,endoplasmic reticulum|integral component of membrane|ER membrane protein complex|,,,30,85,4.43E+10,37.30%
1576,E9QN70,0.00049137,-0.027333333,46.30302463,1.756,2.34E-05,9.249649432,-0.637,-1.063,-1.016,0.83,0.519,1.203,E9QN70,Lamb1,E9QN70_Lamb1,E9QN70,Lamb1,1,14,9,9,E9QN70|P02469,MOUSE,209741,5.6,1138,1138.1,107.3,107.3,NA,1834,Laminin subunit beta-1,proteinaceous extracellular matrix|basement membrane|basal lamina|laminin-1 complex|laminin-2 complex|extracellular space|extracellular matrix|laminin complex|laminin-8 complex|laminin-10 complex|extracellular exosome|basement membrane|,embryo implantation|cell migration|neuronal-glial interaction involved in cerebral cortex radial glia guided migration|positive regulation of cell migration|neuron projection development|substrate adhesion-dependent cell spreading|endodermal cell differentiation|odontogenesis|,integrin binding|extracellular matrix structural constituent|protein binding|enzyme binding|glycosphingolipid binding|,9,14,3.78E+08,5.60%
3245,P07309,0.000599072,-0.0335,45.15870727,1.747666667,3.05E-05,8.904251288,-0.713,-0.96,-1.049,0.707,0.53,1.284,P07309,Ttr,P07309_Ttr,P07309,Ttr,1,3,2,2,P07309,MOUSE,15889.7,10.8,2779,2779.1,19.23,19.23,NA,147,Transthyretin,extracellular space|protein complex|extracellular exosome|,retinol metabolic process|thyroid hormone transport|,hormone activity|protein binding|identical protein binding|protein heterodimerization activity|thyroid hormone binding|,2,3,94500000,10.80%
542,Q8BSY0,3.68E-05,-0.126333333,61.48750605,1.735333333,7.10E-07,14.66270311,-0.913,-0.894,-1.175,0.788,0.569,0.867,Q8BSY0,Asph,Q8BSY0_Asph,Q8BSY0,Asph,1,44,25,24,Q8BSY0|A2AL85|Q8CBM2|A2AL81|Q3TU40|A2AL75|A2AL78|Q8BSY0-2|Q9CR06|A2AL76|A2AL74,MOUSE,83440,41.9,319,319.1,322.97,297.36,NA,741,Aspartyl/asparaginyl beta-hydroxylase,cytoplasm|endoplasmic reticulum|plasma membrane|integral component of membrane|integral component of endoplasmic reticulum membrane|cortical endoplasmic reticulum|sarcoplasmic reticulum membrane|,"pattern specification process|negative regulation of cell proliferation|positive regulation of calcium ion transport into cytosol|regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity|regulation of protein stability|activation of store-operated calcium channel activity|response to ATP|limb morphogenesis|peptidyl-aspartic acid hydroxylation|positive regulation of proteolysis|positive regulation of transcription, DNA-templated|oxidation-reduction process|palate development|face morphogenesis|calcium ion transmembrane transport|cellular response to calcium ion|positive regulation of intracellular protein transport|activation of cysteine-type endopeptidase activity|regulation of protein depolymerization|",peptide-aspartate beta-dioxygenase activity|calcium ion binding|protein binding|,26,44,1.37E+10,41.90%
1494,Q99LI2,1.06E-05,-0.283833333,73.6086154,1.735,4.36E-08,21.28966519,-1.162,-1.104,-1.188,0.66,0.543,0.548,Q99LI2,Clcc1,Q99LI2_Clcc1,Q99LI2,Clcc1,1,14,9,9,A2AEM2|Q99LI2,MOUSE,61418.9,20,1069,1069.1,115.1,115.1,NA,539,Chloride channel CLIC-like protein 1,nucleus|endoplasmic reticulum|Golgi apparatus|membrane|chloride channel complex|intracellular membrane-bounded organelle|,chloride transmembrane transport|,chloride channel activity|,9,14,1.26E+09,20.00%
1827,Q3TQC7,1.06E-05,-0.301333333,74.03526727,1.718666667,3.95E-08,21.56888489,-1.234,-1.127,-1.121,0.557,0.581,0.536,Q3TQC7,Entpd5,Q3TQC7_Entpd5,Q3TQC7,Entpd5,1,14,5,5,Q3TQC7|Q9WUZ9,MOUSE,50293.2,16.5,1367,1367.1,81.46,81.46,NA,452,Ectonucleoside triphosphate diphosphohydrolase 5,extracellular exosome|,metabolic process|,hydrolase activity|,5,14,5.57E+08,16.50%
1457,O08601-2,3.97E-05,-0.250333333,60.89916058,1.704666667,8.13E-07,14.39713879,-1.2,-1.185,-0.923,0.777,0.551,0.478,O08601,Mttp,O08601-2_Mttp,O08601-2,Mttp,1,15,10,10,O08601-2|O08601,MOUSE,101433.7,13.4,1037,1037.1,119,119,NA,894,Isoform 2 of Microsomal triglyceride transfer protein large subunit,endoplasmic reticulum|rough endoplasmic reticulum|Golgi apparatus|basolateral plasma membrane|brush border membrane|microvillus membrane|membrane-bounded vesicle|receptor complex|,protein lipidation|lipid metabolic process|triglyceride metabolic process|lipid transport|circadian rhythm|cholesterol metabolic process|lipoprotein metabolic process|cholesterol homeostasis|lipoprotein transport|response to calcium ion|,lipid transporter activity|protein binding|lipid binding|apolipoprotein binding|protein heterodimerization activity|,10,15,1.67E+09,13.40%
2522,Q5SSH8,7.11E-05,-0.2785,56.84809663,1.703666667,2.07E-06,12.68671143,-0.897,-1.412,-1.082,0.55,0.641,0.529,Q5SSH8,Cyb5d2,Q5SSH8_Cyb5d2,Q5SSH8,Cyb5d2,1,4,3,3,Q5SSH8,MOUSE,29560.9,12.5,2039,2039.1,40.84,40.84,NA,263,Neuferricin,extracellular region|endomembrane system|membrane|,positive regulation of neuron differentiation|,heme binding|,3,4,1.36E+08,12.50%
1108,Q9D1Q6,3.04E-05,-0.145,62.73511942,1.700666667,5.33E-07,15.2411431,-0.918,-0.905,-1.163,0.773,0.549,0.794,Q9D1Q6,Erp44,Q9D1Q6_Erp44,Q9D1Q6,Erp44,1,39,13,13,Q9D1Q6,MOUSE,47251.5,30.2,733,733.1,172.39,172.39,NA,406,Endoplasmic reticulum resident protein 44,endoplasmic reticulum lumen|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|cell surface|extracellular exosome|,protein folding|response to unfolded protein|glycoprotein metabolic process|response to endoplasmic reticulum stress|cell redox homeostasis|,protein disulfide isomerase activity|protein binding|,13,39,7.13E+09,30.20%
1027,Q9CXY9,2.35E-05,-0.151833333,64.22487149,1.697,3.78E-07,15.96004198,-1.014,-1.021,-0.966,0.808,0.49,0.792,Q9CXY9,Pigk,Q9CXY9_Pigk,Q9CXY9,Pigk,1,33,14,14,Q9CXY9|Q8BXX3|E9Q421|Q8BL63|A0A0G2JEZ9,MOUSE,45236.8,46,666,666.1,188.23,188.23,NA,395,GPI-anchor transamidase,membrane|GPI-anchor transamidase complex|,proteolysis|attachment of GPI anchor to protein|,GPI-anchor transamidase activity|cysteine-type peptidase activity|,14,33,5.66E+10,46.00%
51,E9Q401,1.06E-05,-0.279333333,71.64870651,1.695333333,6.84E-08,20.05139763,-1.207,-1.123,-1.051,0.536,0.537,0.632,E9Q401,Ryr2,E9Q401_Ryr2,E9Q401,Ryr2,1,400,158,143,E9Q401|F6U7V1|Q80ZZ5,MOUSE,570001.1,38.6,16,16.1,2213.31,2028.92,NA,4966,Ryanodine receptor 2,smooth endoplasmic reticulum|membrane|integral component of membrane|sarcoplasmic reticulum|sarcomere|Z disc|sarcoplasmic reticulum membrane|calcium channel complex|protein complex|extracellular exosome|,response to hypoxia|regulation of heart rate|embryonic heart tube morphogenesis|left ventricular cardiac muscle tissue morphogenesis|cardiac muscle hypertrophy|detection of calcium ion|calcium ion transport|cellular calcium ion homeostasis|positive regulation of heart rate|regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion|regulation of cardiac muscle contraction by calcium ion signaling|release of sequestered calcium ion into cytosol by sarcoplasmic reticulum|response to muscle activity|calcium-mediated signaling|BMP signaling pathway|response to caffeine|calcium-mediated signaling using intracellular calcium source|response to muscle stretch|release of sequestered calcium ion into cytosol|positive regulation of sequestering of calcium ion|response to redox state|regulation of cardiac muscle contraction|cardiac muscle contraction|canonical Wnt signaling pathway|cytosolic calcium ion transport|calcium ion transport into cytosol|calcium ion transmembrane transport|cellular response to caffeine|cellular response to epinephrine stimulus|establishment of protein localization to endoplasmic reticulum|ventricular cardiac muscle cell action potential|Purkinje myocyte to ventricular cardiac muscle cell signaling|type B pancreatic cell apoptotic process|positive regulation of the force of heart contraction|regulation of AV node cell action potential|regulation of SA node cell action potential|regulation of atrial cardiac muscle cell action potential|regulation of ventricular cardiac muscle cell action potential|positive regulation of calcium-transporting ATPase activity|,intracellular ligand-gated calcium channel activity|ryanodine-sensitive calcium-release channel activity|calcium channel activity|calcium ion binding|protein binding|calmodulin binding|calcium-release channel activity|enzyme binding|protein kinase binding|protein kinase A catalytic subunit binding|protein kinase A regulatory subunit binding|identical protein binding|protein self-association|suramin binding|calcium-induced calcium release activity|organic cyclic compound binding|,158,400,9.02E+10,38.60%
676,Q61838,0.000494052,-0.164666667,46.21591013,1.693333333,2.39E-05,9.222959038,-1.059,-0.896,-1.079,0.367,1.112,0.567,Q61838,NotFound,Q61838_NotFound,Q61838,Pzp,1,52,23,23,Q61838|F1MI18|F1MJK3,MOUSE,167218.8,20.2,393,393.1,288.73,288.73,NA,1495,Pregnancy zone protein,extracellular region|extracellular space|,embryo implantation|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|protein complex binding|,24,52,1.26E+10,20.20%
1699,Q6PHS9,0.000495207,-0.150833333,46.16395846,1.684333333,2.42E-05,9.207073349,-1.197,-0.901,-0.881,1.101,0.472,0.501,Q6PHS9,Cacna2d2,Q6PHS9_Cacna2d2,Q6PHS9,Cacna2d2,1,13,9,9,Q6PHS9|Q6PHS9-2|Q6PHS9-4|Q6PHS9-6|E9Q683|Q6PHS9-3|Q6PHS9-5,MOUSE,131580.6,8,1247,1247.1,94.76,94.76,NA,1154,Voltage-dependent calcium channel subunit alpha-2/delta-2,voltage-gated calcium channel complex|,calcium ion transport|neuromuscular junction development|regulation of ion transmembrane transport|regulation of multicellular organism growth|positive regulation of organ growth|muscle fiber development|regulation of calcium ion transport|rhythmic synaptic transmission|calcium ion transmembrane transport|,voltage-gated calcium channel activity|calcium channel regulator activity|metal ion binding|,9,13,1.10E+09,8.00%
789,Q9ER58,2.15E-05,-0.210333333,65.35046937,1.682666667,2.92E-07,16.52439573,-1.184,-0.896,-1.075,0.696,0.541,0.656,Q9ER58,Spock2,Q9ER58_Spock2,Q9ER58,Spock2,1,44,18,18,Q9ER58|F6SLR4,MOUSE,48231.6,46.8,477,477.1,246.63,246.63,NA,423,Testican-2,proteinaceous extracellular matrix|,signal transduction|positive regulation of cell-substrate adhesion|peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|extracellular matrix organization|,calcium ion binding|glycosaminoglycan binding|extracellular matrix binding|,18,44,1.13E+10,46.80%
1860,Q61704,0.000594865,-0.145,45.22001658,1.682,3.01E-05,8.922474484,-0.793,-1.292,-0.873,1.042,0.609,0.437,Q61704,Itih3,Q61704_Itih3,Q61704,Itih3,1,11,5,5,Q61704,MOUSE,99698.3,7.1,1398,1398.1,78.71,78.71,NA,889,Inter-alpha-trypsin inhibitor heavy chain H3,extracellular exosome|,negative regulation of endopeptidase activity|hyaluronan metabolic process|,serine-type endopeptidase inhibitor activity|,5,11,2.81E+09,7.10%
2061,Q91XD7,7.49E-05,-0.2525,56.51026427,1.675,2.23E-06,12.55291896,-1.206,-0.792,-1.272,0.636,0.585,0.534,Q91XD7,Creld1,Q91XD7_Creld1,Q91XD7,Creld1,1,12,5,5,Q91XD7,MOUSE,47999.2,16.1,1584,1584.1,63.92,63.92,NA,420,Cysteine-rich with EGF-like domain protein 1,integral component of membrane|,,calcium ion binding|,5,12,1.29E+09,16.10%
2174,O54998,0.000147269,-0.142333333,52.61984316,1.660666667,5.47E-06,11.10213657,-1.21,-0.913,-0.795,0.747,0.439,0.878,O54998,Fkbp7,O54998_Fkbp7,O54998,Fkbp7,1,7,5,5,O54998|H3BJI5,MOUSE,25198,20.6,1694,1694.1,56.6,56.6,NA,218,Peptidyl-prolyl cis-trans isomerase FKBP7,cytoplasm|endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum membrane|,protein peptidyl-prolyl isomerization|chaperone-mediated protein folding|,peptidyl-prolyl cis-trans isomerase activity|calcium ion binding|protein binding|FK506 binding|,5,7,1.04E+09,20.60%
278,Q8BHN3-2,1.85E-05,-0.198,66.46865117,1.658666667,2.25E-07,17.10379227,-1.117,-1.015,-0.95,0.649,0.501,0.744,Q8BHN3,Ganab,Q8BHN3-2_Ganab,Q8BHN3-2,Ganab,1,114,40,40,Q8BHN3-2|Q8BHN3|Q8BHN3-3,MOUSE,109858.4,43.3,132,132.1,592.52,592.52,NA,944,Isoform 2 of Neutral alpha-glucosidase AB,endoplasmic reticulum|Golgi apparatus|membrane|glucosidase II complex|melanosome|extracellular exosome|,N-glycan processing|,"protein binding|glucosidase activity|carbohydrate binding|glucan 1,3-alpha-glucosidase activity|poly(A) RNA binding|",40,114,4.90E+10,43.30%
518,Q6GQT9,1.29E-05,-0.233666667,69.61541544,1.650666667,1.09E-07,18.84042535,-1.156,-0.945,-1.076,0.619,0.562,0.594,Q6GQT9,Nomo1,Q6GQT9_Nomo1,Q6GQT9,Nomo1,1,53,25,25,Q6GQT9,MOUSE,134444.5,30.8,302,302.1,334.15,334.15,NA,1214,Nodal modulator 1,endoplasmic reticulum membrane|membrane|integral component of membrane|,,carbohydrate binding|,25,53,9.45E+09,30.80%
1969,Q99P47,0.000244632,-0.222,50.15051995,1.646,9.66E-06,10.26130481,-1.345,-0.804,-0.986,0.831,0.504,0.468,Q99P47,Cntnap4,Q99P47_Cntnap4,Q99P47,Cntnap4,1,10,5,5,D3YWB9|Q99P47,MOUSE,146724.5,4.7,1499,1499.1,70.98,70.98,NA,1310,Contactin-associated protein-like 4,integral component of membrane|cell junction|dendrite|presynaptic membrane|,"cell adhesion|regulation of synaptic transmission, dopaminergic|regulation of synaptic transmission, GABAergic|regulation of grooming behavior|",protein binding|,5,10,2.97E+08,4.70%
949,Q8K4Z0-2,1.06E-05,-0.260333333,70.94720663,1.644,8.04E-08,19.62535728,-1.164,-1.066,-1.017,0.617,0.556,0.512,Q8K4Z0,Lgi2,Q8K4Z0-2_Lgi2,Q8K4Z0-2,Lgi2,1,31,16,16,Q8K4Z0-2|Q8K4Z0,MOUSE,62638.4,30.6,604,604.1,205.75,205.75,NA,550,Isoform 2 of Leucine-rich repeat LGI family member 2,extracellular region|,,,16,31,9.90E+09,30.60%
2889,Q62356,0.006415587,-0.010333333,33.16729556,1.634666667,0.000482248,5.869654555,-0.29,-0.977,-1.216,0.328,1.006,1.087,Q62356,Fstl1,Q62356_Fstl1,Q62356,Fstl1,1,4,3,3,Q62356,MOUSE,35694.4,12.4,2402,2402.1,27.84,27.84,NA,306,Follistatin-related protein 1,extracellular space|extracellular exosome|,response to starvation|,calcium ion binding|protein binding|heparin binding|,3,4,27200000,12.40%
884,Q3TVI8,5.43E-05,-0.155166667,58.54000639,1.630333333,1.40E-06,13.37674266,-0.986,-0.98,-0.945,0.497,0.56,0.923,Q3TVI8,Pbxip1,Q3TVI8_Pbxip1,Q3TVI8,Pbxip1,1,33,15,15,Q3TVI8,MOUSE,81562.4,27.7,551,551.1,220.97,220.97,NA,727,Pre-B-cell leukemia transcription factor-interacting protein 1,nucleus|cytoplasm|microtubule|,,,15,33,4.08E+09,27.70%
1516,Q91W90,2.64E-05,-0.249,63.43100395,1.621333333,4.54E-07,15.57305442,-1.22,-0.989,-0.97,0.544,0.467,0.674,Q91W90,Txndc5,Q91W90_Txndc5,Q91W90,Txndc5,1,19,8,8,Q91W90|E9PXX7|A0A0R4J1Y7,MOUSE,47099.3,24.2,1086,1086.1,113.12,113.12,NA,417,Thioredoxin domain-containing protein 5,endoplasmic reticulum lumen|extracellular exosome|,protein folding|response to endoplasmic reticulum stress|apoptotic cell clearance|cell redox homeostasis|,protein disulfide isomerase activity|,8,19,4.47E+09,24.20%
1618,Q9EPK6,1.84E-05,-0.0945,66.81781117,1.616333333,2.08E-07,17.28864737,-0.959,-0.886,-0.863,0.71,0.59,0.841,Q9EPK6,Sil1,Q9EPK6_Sil1,Q9EPK6,Sil1,1,13,8,8,Q9EPK6,MOUSE,52771.3,28.8,1175,1175.1,102.84,102.84,NA,465,Nucleotide exchange factor SIL1,extracellular space|endoplasmic reticulum|endoplasmic reticulum lumen|,protein transport|,,8,13,1.27E+09,28.80%
539,Q8BP92,1.75E-05,-0.200666667,67.50885536,1.614666667,1.77E-07,17.66014957,-1.002,-0.992,-1.03,0.552,0.518,0.75,Q8BP92,Rcn2,Q8BP92_Rcn2,Q8BP92,Rcn2,1,53,19,19,Q8BP92|D6RHL9,MOUSE,37270.1,55.3,317,317.1,325.13,325.13,NA,320,Reticulocalbin-2,nucleolus|endoplasmic reticulum|endoplasmic reticulum lumen|,,calcium ion binding|protein binding|,19,53,2.62E+10,55.30%
2957,Q8VHC3,0.000115874,-0.119833333,54.1300996,1.610333333,3.86E-06,11.64623229,-0.66,-0.967,-1.148,0.832,0.583,0.641,Q8VHC3,Selenom,Q8VHC3_Selenom,Q8VHC3,Selenom,1,2,2,2,Q8VHC3,MOUSE,16420.7,20,2470,2470.1,25.96,25.96,NA,145,Selenoprotein M,nucleoplasm|cytoplasm|endoplasmic reticulum|Golgi apparatus|perinuclear region of cytoplasm|,response to selenium ion|multicellular organism growth|corticosterone secretion|hormone metabolic process|adipose tissue development|,,2,2,92400000,20.00%
61,Q91ZX7,2.15E-05,-0.162666667,65.10588504,1.608666667,3.09E-07,16.40017699,-0.923,-1.07,-0.908,0.72,0.499,0.706,Q91ZX7,Lrp1,Q91ZX7_Lrp1,Q91ZX7,Lrp1,1,340,132,126,A0A0R4J0I9|Q91ZX7|Q3U5J2|D3Z5M3,MOUSE,523675.1,34.2,19,19.1,1807.41,1742.22,NA,4545,Prolow-density lipoprotein receptor-related protein 1,nucleolus|cytoplasm|lysosomal membrane|integral component of plasma membrane|coated pit|focal adhesion|membrane|receptor complex|perinuclear region of cytoplasm|,receptor-mediated endocytosis|cholesterol metabolic process|positive regulation of cholesterol efflux|negative regulation of smooth muscle cell migration|negative regulation of Wnt signaling pathway|positive regulation of lipid transport|regulation of cholesterol transport|regulation of phospholipase A2 activity|regulation of actin cytoskeleton organization|aorta morphogenesis|apoptotic cell clearance|beta-amyloid clearance|negative regulation of platelet-derived growth factor receptor-beta signaling pathway|,calcium ion binding|protein binding|protein complex binding|apolipoprotein binding|poly(A) RNA binding|,132,340,1.03E+11,34.20%
1182,P55066,0.000100433,-0.187666667,55.06716585,1.608666667,3.11E-06,11.99582197,-1.172,-0.912,-0.892,0.422,0.578,0.85,P55066,Ncan,P55066_Ncan,P55066,Ncan,1,25,17,17,P55066|A0A0R4IZX5,MOUSE,139137.7,13.9,801,801.1,161.15,161.15,NA,1268,Neurocan core protein,proteinaceous extracellular matrix|plasma membrane|,skeletal system development|cell adhesion|central nervous system development|regulation of synapse structural plasticity|,calcium ion binding|hyaluronic acid binding|carbohydrate binding|,17,25,1.95E+09,13.90%
3078,Q6P2L7,0.001911789,0.1075,39.05381693,1.608333333,0.000124342,7.237090581,-0.864,-0.59,-0.636,1.228,0.366,1.141,Q6P2L7,Casc4,Q6P2L7_Casc4,Q6P2L7,Casc4,1,4,2,2,Q6P2L7|Q6P2L7-2|E9PZJ6|Q6P2L7-3,MOUSE,49521.8,6.2,2598,2598.1,22.91,22.91,NA,435,Protein CASC4,Golgi apparatus|integral component of membrane|,,,2,4,4.51E+08,6.20%
2051,Q9QXT0,1.75E-05,-0.188333333,67.36544739,1.586666667,1.83E-07,17.58243176,-1.049,-1.009,-0.887,0.64,0.505,0.67,Q9QXT0,Cnpy2,Q9QXT0_Cnpy2,Q9QXT0,Cnpy2,1,13,5,5,Q9QXT0,MOUSE,21109.3,26.9,1575,1575.1,65.21,65.21,NA,182,Protein canopy homolog 2,endoplasmic reticulum|,negative regulation of gene expression|regulation of low-density lipoprotein particle clearance|positive regulation of low-density lipoprotein particle receptor biosynthetic process|,,5,13,6.50E+08,26.90%
2001,G3UYX7,0.000104533,-0.218333333,54.81559557,1.584,3.30E-06,11.90104586,-1.038,-1.219,-0.774,0.729,0.456,0.536,G3UYX7,Slit2,G3UYX7_Slit2,G3UYX7,Slit2,1,6,6,6,G3UYX7|A0A140T8T2|G3UY21|Q9R1B9|G3X909,MOUSE,177276,5.4,1528,1528.1,68.18,68.18,NA,1542,Slit homolog 2 protein,extracellular space|cytoplasm|plasma membrane|cell surface|extracellular exosome|,metanephros development|ureteric bud development|in utero embryonic development|negative regulation of protein phosphorylation|cell migration involved in sprouting angiogenesis|negative regulation of leukocyte chemotaxis|axonogenesis|axon guidance|motor neuron axon guidance|negative regulation of cell proliferation|negative regulation of lamellipodium assembly|negative regulation of endothelial cell migration|negative regulation of gene expression|negative regulation of smooth muscle cell migration|single organismal cell-cell adhesion|spinal cord development|olfactory bulb development|chemorepulsion involved in postnatal olfactory bulb interneuron migration|corticospinal neuron axon guidance through spinal cord|telencephalon cell migration|negative regulation of cell growth|negative regulation of cell migration|negative regulation of axon extension|negative regulation of actin filament polymerization|retinal ganglion cell axon guidance|response to nutrient levels|cellular response to hormone stimulus|dorsal/ventral axon guidance|negative regulation of GTPase activity|Roundabout signaling pathway|positive regulation of apoptotic process|negative regulation of vascular permeability|branching morphogenesis of an epithelial tube|neuron projection morphogenesis|axon extension involved in axon guidance|negative regulation of inflammatory response|negative chemotaxis|induction of negative chemotaxis|negative regulation of small GTPase mediated signal transduction|response to cortisol|mammary gland duct morphogenesis|mammary duct terminal end bud growth|apoptotic process involved in luteolysis|negative regulation of chemokine-mediated signaling pathway|cellular response to heparin|negative regulation of smooth muscle cell chemotaxis|negative regulation of mononuclear cell migration|negative regulation of neutrophil chemotaxis|negative regulation of retinal ganglion cell axon guidance|negative regulation of cellular response to growth factor stimulus|,GTPase inhibitor activity|receptor binding|calcium ion binding|protein binding|heparin binding|identical protein binding|protein homodimerization activity|laminin-1 binding|proteoglycan binding|heparan sulfate proteoglycan binding|chemorepellent activity|Roundabout binding|,6,6,2.80E+08,5.40%
587,P19324,8.82E-05,-0.123833333,55.75827666,1.583666667,2.66E-06,12.25973814,-0.96,-1.002,-0.785,0.666,0.444,0.894,P19324,Serpinh1,P19324_Serpinh1,P19324,Serpinh1,1,64,18,18,P19324,MOUSE,46646.9,46.7,342,342.1,308.17,308.17,NA,417,Serpin H1,cytoplasm|endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum-Golgi intermediate compartment|membrane raft|extracellular exosome|extracellular space|,chondrocyte development involved in endochondral bone morphogenesis|negative regulation of endopeptidase activity|collagen fibril organization|collagen biosynthetic process|protein maturation|,serine-type endopeptidase inhibitor activity|protein binding|collagen binding|poly(A) RNA binding|unfolded protein binding|,18,64,2.60E+10,46.70%
1134,Q99KV1,0.000130876,-0.0775,53.34255355,1.578333333,4.63E-06,11.35958257,-0.995,-0.82,-0.785,0.756,0.435,0.944,Q99KV1,Dnajb11,Q99KV1_Dnajb11,Q99KV1,Dnajb11,1,21,11,11,Q99KV1,MOUSE,40839.6,35.4,758,758.1,168.9,168.9,NA,358,DnaJ homolog subfamily B member 11,nucleus|cytoplasm|endoplasmic reticulum|endoplasmic reticulum lumen|membrane|endoplasmic reticulum chaperone complex|,protein folding|mRNA modification|,protein binding|unfolded protein binding|,11,21,2.85E+10,35.40%
882,P81117,3.97E-05,-0.110333333,60.96231504,1.547333333,8.01E-07,14.42542764,-0.962,-0.888,-0.802,0.846,0.52,0.624,P81117,Nucb2,P81117_Nucb2,P81117,Nucb2,1,33,15,15,P81117|Q3UKN6,MOUSE,50417.7,43.5,549,549.1,221.45,221.45,NA,420,Nucleobindin-2,extracellular space|nucleus|nuclear outer membrane|cytoplasm|endoplasmic reticulum|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|Golgi medial cisterna|perikaryon|extracellular exosome|,cellular calcium ion homeostasis|response to glucose|negative regulation of cAMP biosynthetic process|negative regulation of appetite|response to starvation|response to human chorionic gonadotropin|negative regulation of fat cell differentiation|positive regulation of fatty acid oxidation|negative regulation of insulin receptor signaling pathway|negative regulation of glucagon secretion|insulin metabolic process|response to melanocyte-stimulating hormone|positive regulation of testosterone secretion|,DNA binding|tumor necrosis factor receptor binding|calcium ion binding|,15,33,7.71E+09,43.50%
3269,Q8C0L9,0.000682625,-0.084666667,44.49392537,1.545333333,3.55E-05,8.708665866,-0.446,-1.001,-1.125,0.79,0.549,0.725,Q8C0L9,Gpcpd1,Q8C0L9_Gpcpd1,Q8C0L9,Gpcpd1,1,5,2,2,Q8C0L9|Q8C0L9-2|B0R058|Q8C0L9-3,MOUSE,77547.9,3.5,2806,2806.1,18.76,18.76,NA,675,Glycerophosphocholine phosphodiesterase GPCPD1,cytoplasm|cytosol|,lipid metabolic process|skeletal muscle tissue development|,glycerophosphocholine phosphodiesterase activity|starch binding|,2,5,2.76E+08,3.50%
3004,Q9CPT4,0.000127577,-0.1655,53.48946554,1.541,4.48E-06,11.41256756,-1.035,-1.048,-0.725,0.701,0.377,0.737,Q9CPT4,Mydgf,Q9CPT4_Mydgf,Q9CPT4,Mydgf,1,2,2,2,Q9CPT4,MOUSE,18096.1,14.4,2516,2516.1,24.88,24.88,NA,166,Myeloid-derived growth factor,extracellular region|extracellular space|endoplasmic reticulum-Golgi intermediate compartment|extracellular exosome|,angiogenesis|positive regulation of protein phosphorylation|positive regulation of endothelial cell proliferation|apoptotic process|positive regulation of phosphatidylinositol 3-kinase signaling|negative regulation of apoptotic process|positive regulation of MAPK cascade|positive regulation of angiogenesis|positive regulation of transcription from RNA polymerase II promoter|positive regulation of protein kinase B signaling|,,2,2,55800000,14.40%
2313,D3Z4P2,4.31E-05,-0.167333333,60.35811351,1.54,9.21E-07,14.15690531,-1.014,-0.808,-0.99,0.779,0.511,0.518,D3Z4P2,Lman2l,D3Z4P2_Lman2l,D3Z4P2,Lman2l,1,14,5,5,D3Z4P2|P59481,MOUSE,41322.9,11.1,1830,1830.1,49.84,49.84,NA,358,"Lectin, mannose-binding 2-like, isoform CRA_b",endoplasmic reticulum membrane|Golgi apparatus|,protein transport|,,5,14,1.56E+09,11.10%
842,Q9DC23,2.09E-05,-0.154833333,65.69469828,1.529666667,2.69E-07,16.7007388,-0.949,-0.825,-0.985,0.7,0.509,0.621,Q9DC23,Dnajc10,Q9DC23_Dnajc10,Q9DC23,Dnajc10,1,28,19,19,Q9DC23,MOUSE,91950.7,30.7,516,516.1,231.56,231.56,NA,793,DnaJ homolog subfamily C member 10,endoplasmic reticulum|endoplasmic reticulum lumen|membrane|endoplasmic reticulum chaperone complex|,negative regulation of protein phosphorylation|ER-associated ubiquitin-dependent protein catabolic process|positive regulation of ATPase activity|protein folding in endoplasmic reticulum|response to endoplasmic reticulum stress|cell redox homeostasis|oxidation-reduction process|intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress|,"ATPase activator activity|protein binding|protein disulfide oxidoreductase activity|disulfide oxidoreductase activity|oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor|Hsp70 protein binding|chaperone binding|ATPase binding|misfolded protein binding|",19,28,2.51E+09,30.70%
791,Q3TML0,6.42E-05,-0.046833333,57.62526207,1.528333333,1.73E-06,12.99948709,-0.762,-0.763,-0.908,0.771,0.495,0.886,Q3TML0,Pdia6,Q3TML0_Pdia6,Q3TML0,Pdia6,1,57,18,1,Q3TML0|Q0V8C4,MOUSE,49087.6,50.7,479,479.1,246.3,17.79,NA,445,Protein disulfide-isomerase A6,endoplasmic reticulum-Golgi intermediate compartment|extracellular exosome|,protein folding|response to endoplasmic reticulum stress|cell redox homeostasis|,protein disulfide isomerase activity|,18,57,1.21E+10,50.70%
1255,Q6PGJ3,4.55E-05,-0.198833333,60.03679996,1.524333333,9.92E-07,14.01601541,-0.896,-0.949,-1.038,0.713,0.607,0.37,Q6PGJ3,L1cam,Q6PGJ3_L1cam,Q6PGJ3,L1cam,1,21,11,11,Q6PGJ3|A2AFG8|A2AFG7|P11627,MOUSE,141883.8,13.8,851,851.1,148.57,148.57,NA,1259,L1 cell adhesion molecule,focal adhesion|external side of plasma membrane|cell surface|membrane|presynaptic membrane|terminal bouton|,homophilic cell adhesion via plasma membrane adhesion molecules|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|leukocyte cell-cell adhesion|cell surface receptor signaling pathway|axon guidance|positive regulation of cell-cell adhesion|neuron projection development|cell-cell adhesion mediated by integrin|homotypic cell-cell adhesion|positive regulation of calcium-mediated signaling|,integrin binding|protein binding|sialic acid binding|identical protein binding|protein self-association|,11,21,1.14E+09,13.80%
1947,E9Q4X2,3.83E-05,-0.276333333,61.17887065,1.523333333,7.62E-07,14.52282556,-1.156,-1.099,-0.859,0.421,0.46,0.575,E9Q4X2,Uggt2,E9Q4X2_Uggt2,E9Q4X2,Uggt2,1,11,9,9,E9Q4X2,MOUSE,173504.7,6.2,1478,1478.1,72.29,72.29,NA,1504,UDP-glucose glycoprotein glucosyltransferase 2,,protein glycosylation|UDP-glucosylation|,UDP-glucose:glycoprotein glucosyltransferase activity|,9,11,4.83E+09,6.20%
748,Q69ZU6,1.14E-05,-0.162666667,70.28836408,1.520666667,9.36E-08,19.23318903,-0.886,-0.888,-0.995,0.609,0.593,0.591,Q69ZU6,Thsd7a,Q69ZU6_Thsd7a,Q69ZU6,Thsd7a,1,37,22,22,E9QNR5|E9PWD2|Q69ZU6,MOUSE,191111.8,18.7,445,445.1,259,259,NA,1645,Thrombospondin type-1 domain-containing protein 7A,plasma membrane|integral component of membrane|extracellular exosome|,angiogenesis|cell differentiation|,,22,37,1.96E+09,18.70%
2237,G5E8J0,0.000136405,-0.216833333,53.06792184,1.517666667,4.93E-06,11.26112768,-1.1,-1.079,-0.748,0.454,0.42,0.752,G5E8J0,Notch2,G5E8J0_Notch2,G5E8J0,Notch2,1,7,6,6,G5E8J0|O35516|O35516-2,MOUSE,279492.6,3,1756,1756.1,53.27,53.27,NA,2473,Neurogenic locus notch homolog protein 2,nucleus|integral component of plasma membrane|cell surface|receptor complex|,pulmonary valve morphogenesis|cell cycle arrest|Notch signaling pathway|negative regulation of cell proliferation|cell growth|cell differentiation|positive regulation of Ras protein signal transduction|bone remodeling|regulation of developmental process|atrial septum morphogenesis|,calcium ion binding|,6,7,1.41E+08,3.00%
1258,Q8VEH8,1.38E-05,-0.178,68.76521554,1.516,1.33E-07,18.35523285,-0.882,-0.916,-1.01,0.619,0.519,0.602,Q8VEH8,Erlec1,Q8VEH8_Erlec1,Q8VEH8,Erlec1,1,24,10,10,Q8VEH8,MOUSE,55704,27.7,854,854.1,147.72,147.72,NA,483,Endoplasmic reticulum lectin 1,endoplasmic reticulum lumen|,"ER-associated ubiquitin-dependent protein catabolic process|negative regulation of retrograde protein transport, ER to cytosol|",glycoprotein binding|,10,24,3.41E+09,27.70%
2502,Q9WTK3,0.000422894,5.00E-04,47.14103705,1.511,1.93E-05,9.312482746,-0.905,-0.569,-0.791,1.034,0.438,0.796,Q9WTK3,Gpaa1,Q9WTK3_Gpaa1,Q9WTK3,Gpaa1,1,7,3,3,Q9WTK3|E9PW03,MOUSE,68289.7,5.3,2018,2018.1,41.8,41.8,NA,621,Glycosylphosphatidylinositol anchor attachment 1 protein,integral component of plasma membrane|membrane|GPI-anchor transamidase complex|,GPI anchor biosynthetic process|,GPI-anchor transamidase activity|GPI anchor binding|,3,7,4.27E+08,5.30%
1429,Q640L3-2,2.18E-05,-0.146333333,64.9360868,1.502,3.21E-07,16.31446296,-0.861,-0.949,-0.882,0.63,0.473,0.711,Q640L3,Ccpg1,Q640L3-2_Ccpg1,Q640L3-2,Ccpg1,1,22,13,13,Q640L3-2|D3Z7R9|Q640L3|Q640L3-3,MOUSE,92733.4,19.4,1010,1010.1,123.3,123.3,NA,753,Isoform 2 of Cell cycle progression protein 1,membrane|integral component of membrane|,cell cycle|positive regulation of cell proliferation|positive regulation of cell cycle|positive regulation of transcription from RNA polymerase II promoter|regulation of Rho guanyl-nucleotide exchange factor activity|,protein binding|,13,22,1.33E+09,19.40%
62,Q9JI18,2.19E-05,-0.217333333,64.76949045,1.484,3.33E-07,16.23077898,-1.086,-0.953,-0.839,0.504,0.513,0.557,Q9JI18,NotFound,Q9JI18_NotFound,Q9JI18,Lrp1b,1,221,107,101,Q9JI18|A2API5|E9Q202|A0A087WPQ4,MOUSE,533366.2,27.5,19,19.2,1447.77,1382.58,NA,4599,Low-density lipoprotein receptor-related protein 1B,membrane|integral component of membrane|receptor complex|,receptor-mediated endocytosis|,low-density lipoprotein receptor activity|calcium ion binding|protein binding|low-density lipoprotein particle receptor binding|,101,221,4.13E+10,26.80%
398,P70302,6.81E-05,-0.0895,57.14207049,1.463666667,1.93E-06,12.80419933,-0.828,-0.656,-0.98,0.727,0.493,0.707,P70302,Stim1,P70302_Stim1,P70302,Stim1,1,50,20,20,A0A1B0GRA5|P70302|A0A1B0GR78,MOUSE,77850.5,31.8,218,218.2,257.23,248.17,NA,685,Stromal interaction molecule 1,endoplasmic reticulum|microtubule|integral component of plasma membrane|integral component of endoplasmic reticulum membrane|cortical endoplasmic reticulum|protein complex|,store-operated calcium entry|detection of calcium ion|cation transport|myotube differentiation|activation of store-operated calcium channel activity|regulation of calcium ion transport|enamel mineralization|,protease binding|calcium channel regulator activity|calcium ion binding|protein binding|identical protein binding|microtubule plus-end binding|,20,50,9.26E+09,29.40%
274,Q8CJH3,1.75E-05,-0.1575,67.35306119,1.456333333,1.84E-07,17.57573462,-0.937,-0.88,-0.84,0.582,0.494,0.636,Q8CJH3,Plxnb1,Q8CJH3_Plxnb1,Q8CJH3,Plxnb1,1,131,41,41,Q8CJH3|Q9QY40,MOUSE,234738.4,27.2,129,129.1,602.28,602.28,NA,2119,Plexin-B1,semaphorin receptor complex|integral component of plasma membrane|,negative regulation of cell adhesion|regulation of cell shape|positive regulation of phosphatidylinositol 3-kinase signaling|negative regulation of osteoblast proliferation|positive regulation of GTPase activity|ossification involved in bone maturation|neuron projection morphogenesis|positive regulation of axonogenesis|regulation of cytoskeleton organization|semaphorin-plexin signaling pathway|semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis|,protein binding|semaphorin receptor activity|GTPase activating protein binding|,43,131,2.90E+10,27.20%
2394,Q80Y,0.000776884,0.043833333,43.81091661,1.452333333,4.16E-05,8.43333007,-0.438,-0.78,-0.829,1.014,0.431,0.865,Q80Y,NotFound,Q80Y_NotFound,Q80Y,Tnc,1,6,6,6,Q80Y|Q80Y-2|Q80Y-3|Q80Y-4|Q80Y-5|Q80YX0,MOUSE,237451.3,3,1911,1911.1,46.47,46.47,NA,2110,Tenascin,extracellular region|basement membrane|interstitial matrix|extracellular space|focal adhesion|membrane|extracellular matrix|extracellular matrix|,osteoblast differentiation|cell adhesion|neuromuscular junction development|positive regulation of cell proliferation|positive regulation of gene expression|peripheral nervous system axon regeneration|mesenchymal-epithelial cell signaling involved in prostate gland development|prostate gland epithelium morphogenesis|,fibronectin binding|syndecan binding|,6,6,1.06E+08,3.00%
2905,Q6PD26,0.000315923,-0.159666667,48.75955003,1.446,1.33E-05,9.81282464,-1.098,-0.923,-0.627,0.736,0.36,0.594,Q6PD26,Pigs,Q6PD26_Pigs,Q6PD26,Pigs,1,4,2,2,Q6PD26,MOUSE,61823.5,5.2,2418,2418.1,27.38,27.38,NA,555,GPI transamidase component PIG-S,membrane|GPI-anchor transamidase complex|,attachment of GPI anchor to protein|,GPI-anchor transamidase activity|,2,4,2.27E+08,5.20%
1199,Q8VBZ3,1.85E-05,-0.212,66.42579527,1.443333333,2.28E-07,17.0812336,-0.956,-1.001,-0.844,0.51,0.56,0.459,Q8VBZ3,Clptm1,Q8VBZ3_Clptm1,Q8VBZ3,Clptm1,1,27,12,12,Q8VBZ3,MOUSE,75631.6,26.5,814,814.1,157.91,157.91,NA,664,Cleft lip and palate transmembrane protein 1 homolog,external side of plasma membrane|membrane|integral component of membrane|,multicellular organismal development|cell differentiation|regulation of T cell differentiation in thymus|,,12,27,9.51E+09,26.50%
1216,Q9D024,4.09E-05,-0.149833333,60.70921422,1.437666667,8.49E-07,14.31236856,-0.901,-0.963,-0.742,0.563,0.458,0.686,Q9D024,Ccdc47,Q9D024_Ccdc47,Q9D024,Ccdc47,1,26,11,11,Q9D024|Q9D024-2|Q9D024-3,MOUSE,56128.1,28.5,827,827.1,155.51,155.51,NA,483,Coiled-coil domain-containing protein 47,endoplasmic reticulum|rough endoplasmic reticulum|membrane|integral component of membrane|,osteoblast differentiation|ER overload response|endoplasmic reticulum organization|post-embryonic development|ER-associated ubiquitin-dependent protein catabolic process|calcium ion homeostasis|,calcium ion binding|poly(A) RNA binding|,11,26,5.16E+09,28.50%
839,Q61361,3.78E-05,-0.198166667,61.30607845,1.435666667,7.40E-07,14.58032547,-0.74,-0.985,-1.023,0.506,0.522,0.531,Q61361,Bcan,Q61361_Bcan,Q61361,Bcan,1,32,20,20,Q61361,MOUSE,97353.7,23.7,513,513.1,232.91,232.91,NA,883,Brevican core protein,proteinaceous extracellular matrix|extracellular space|dendrite|anchored component of membrane|synapse|,skeletal system development|cell adhesion|central nervous system development|hippocampus development|regulation of neuronal synaptic plasticity|,hyaluronic acid binding|carbohydrate binding|,20,32,5.36E+09,23.70%
1865,Q6ZQI3,0.000115988,-0.036,54.08787126,1.422,3.90E-06,11.63069792,-0.718,-0.784,-0.739,0.854,0.416,0.755,Q6ZQI3,Mlec,Q6ZQI3_Mlec,Q6ZQI3,Mlec,1,14,6,6,Q6ZQI3,MOUSE,32512.6,23,1402,1402.1,78.34,78.34,NA,291,Malectin,endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of membrane|,carbohydrate metabolic process|,enzyme binding|carbohydrate binding|,6,14,4.72E+09,23.00%
992,Q00623,0.005029894,-0.0725,34.39643348,1.417666667,0.000363376,6.138188091,-0.863,-0.834,-0.647,0.254,1.209,0.446,Q00623,Apoa1,Q00623_Apoa1,Q00623,Apoa1,1,42,16,16,Q00623,MOUSE,30615,50,639,639.1,195.03,195.03,NA,264,Apolipoprotein A-I,extracellular region|extracellular space|nucleus|cytosol|cell surface|endocytic vesicle|cytoplasmic vesicle|very-low-density lipoprotein particle|high-density lipoprotein particle|discoidal high-density lipoprotein particle|spherical high-density lipoprotein particle|chylomicron|extracellular exosome|blood microparticle|extracellular vesicle|,regulation of protein phosphorylation|endothelial cell proliferation|negative regulation of cytokine secretion involved in immune response|phospholipid metabolic process|phosphatidylcholine biosynthetic process|cholesterol biosynthetic process|G-protein coupled receptor signaling pathway|integrin-mediated signaling pathway|response to nutrient|cholesterol metabolic process|glucocorticoid metabolic process|negative regulation of tumor necrosis factor-mediated signaling pathway|positive regulation of cholesterol esterification|positive regulation of triglyceride catabolic process|negative regulation of very-low-density lipoprotein particle remodeling|protein oxidation|peptidyl-methionine modification|triglyceride catabolic process|lipid storage|regulation of intestinal cholesterol absorption|cholesterol transport|adrenal gland development|organ regeneration|regulation of Cdc42 protein signal transduction|cholesterol efflux|phospholipid efflux|negative regulation of heterotypic cell-cell adhesion|very-low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|positive regulation of Rho protein signal transduction|lipoprotein biosynthetic process|response to drug|cholesterol homeostasis|blood vessel endothelial cell migration|response to estrogen|reverse cholesterol transport|positive regulation of fatty acid biosynthetic process|phosphatidylcholine metabolic process|negative regulation of interleukin-1 beta secretion|negative regulation of inflammatory response|protein stabilization|negative chemotaxis|positive regulation of lipoprotein lipase activity|vitamin transport|positive regulation of hydrolase activity|negative regulation of hydrolase activity|positive regulation of stress fiber assembly|phospholipid homeostasis|negative regulation of lipase activity|negative regulation of cell adhesion molecule production|negative regulation of response to cytokine stimulus|triglyceride homeostasis|cholesterol import|positive regulation of substrate adhesion-dependent cell spreading|protein localization|axon regeneration|,beta-amyloid binding|lipid transporter activity|protein binding|phospholipid binding|phospholipid transporter activity|high-density lipoprotein particle binding|lipid binding|cholesterol binding|cholesterol transporter activity|enzyme binding|phosphatidylcholine binding|apolipoprotein receptor binding|apolipoprotein A-I receptor binding|identical protein binding|chemorepellent activity|lipase inhibitor activity|phosphatidylcholine-sterol O-acyltransferase activator activity|high-density lipoprotein particle receptor binding|lipoprotein particle binding|cholesterol transporter activity|,16,42,6.38E+09,50.00%
2133,P07214,0.000259011,-0.037166667,49.74452818,1.412333333,1.06E-05,10.12858796,-0.514,-0.913,-0.803,0.691,0.466,0.85,P07214,Sparc,P07214_Sparc,P07214,Sparc,1,10,6,6,A0A1L1SSH9|P07214|Q5NCU4,MOUSE,35305.2,21.5,1654,1654.1,59.21,59.21,NA,302,SPARC,proteinaceous extracellular matrix|basement membrane|extracellular space|cell surface|nuclear matrix|platelet alpha granule|platelet alpha granule membrane|,negative regulation of endothelial cell proliferation|signal transduction|heart development|response to gravity|response to lead ion|positive regulation of endothelial cell migration|negative regulation of angiogenesis|regulation of cell morphogenesis|lung development|response to lipopolysaccharide|response to L-ascorbic acid|response to cytokine|wound healing|regulation of cell proliferation|response to peptide hormone|response to ethanol|response to cadmium ion|inner ear development|response to glucocorticoid|response to cAMP|response to calcium ion|bone development|cellular response to growth factor stimulus|,calcium ion binding|collagen binding|extracellular matrix binding|,6,10,8.12E+08,21.50%
78,P70227,5.13E-05,-0.2035,59.15060309,1.401,1.22E-06,13.63417906,-0.992,-0.987,-0.733,0.592,0.451,0.448,P70227,Itpr3,P70227_Itpr3,P70227,Itpr3,1,30,29,20,P70227,MOUSE,307122.1,12.8,26,26.4,375.09,259.96,NA,2670,"Inositol 1,4,5-trisphosphate receptor type 3",nucleus|nucleoplasm|nucleolus|cytoplasm|endoplasmic reticulum membrane|plasma membrane|integral component of plasma membrane|membrane|receptor complex|,calcium ion transport|memory|inositol phosphate-mediated signaling|sensory perception of bitter taste|sensory perception of sweet taste|sensory perception of umami taste|response to calcium ion|long-term synaptic potentiation|calcium ion transport into cytosol|calcium ion transmembrane transport|,"intracellular ligand-gated calcium channel activity|inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity|protein binding|phosphatidylinositol binding|inositol 1,4,5 trisphosphate binding|",20,30,1.22E+09,10.60%
1990,Q61543,3.68E-05,-0.1645,61.49259576,1.399666667,7.09E-07,14.66502039,-0.912,-0.93,-0.751,0.563,0.421,0.622,Q61543,Glg1,Q61543_Glg1,Q61543,Glg1,1,8,6,6,Q61543,MOUSE,137611.2,8.1,1517,1517.1,68.8,68.8,NA,1175,Golgi apparatus protein 1,Golgi membrane|proteinaceous extracellular matrix|Golgi apparatus|plasma membrane|membrane|integral component of membrane|extracellular exosome|,negative regulation of protein processing|negative regulation of transforming growth factor beta receptor signaling pathway|regulation of chondrocyte differentiation|bone morphogenesis|,,6,8,1.66E+08,8.10%
2470,Q9R1V7-2,5.43E-05,-0.202833333,58.53447683,1.390333333,1.40E-06,13.37443205,-0.782,-1.006,-0.906,0.341,0.549,0.587,Q9R1V7,Adam23,Q9R1V7-2_Adam23,Q9R1V7-2,Adam23,1,6,4,4,Q9R1V7-2|Q9R1V7|Q9R1V7-3|Q9R1V7-4,MOUSE,94276.6,5.4,1986,1986.1,43.3,43.3,NA,829,Isoform Beta of Disintegrin and metalloproteinase domain-containing protein 23,extracellular region|plasma membrane|integral component of membrane|,proteolysis|cell adhesion|,metalloendopeptidase activity|protein binding|zinc ion binding|,4,6,3.20E+08,5.40%
1840,Q3TDQ1,2.22E-05,-0.153666667,64.63769153,1.380666667,3.44E-07,16.16486323,-0.882,-0.863,-0.787,0.629,0.458,0.523,Q3TDQ1,Stt3b,Q3TDQ1_Stt3b,Q3TDQ1,Stt3b,1,14,8,8,A0A0R4J0D3|Q3TDQ1,MOUSE,93814.5,9.7,1378,1378.1,80.64,80.64,NA,823,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B,endoplasmic reticulum|oligosaccharyltransferase complex|membrane|integral component of membrane|,glycoprotein catabolic process|response to unfolded protein|protein N-linked glycosylation via asparagine|ER-associated ubiquitin-dependent protein catabolic process|co-translational protein modification|post-translational protein modification|,dolichyl-diphosphooligosaccharide-protein glycotransferase activity|dolichyl-diphosphooligosaccharide-protein glycotransferase activity|,8,14,1.15E+09,9.70%
2088,Q9CYN9,6.81E-05,-0.171,57.17479185,1.358666667,1.92E-06,12.81733827,-0.776,-0.934,-0.841,0.651,0.542,0.332,Q9CYN9,Atp6ap2,Q9CYN9_Atp6ap2,Q9CYN9,Atp6ap2,1,6,4,4,Q9CYN9,MOUSE,39091.2,15.7,1610,1610.1,61.65,61.65,NA,350,Renin receptor,external side of plasma membrane|integral component of membrane|neuron projection|cell body|extracellular exosome|,angiotensin maturation|rostrocaudal neural tube patterning|positive regulation of Wnt signaling pathway|positive regulation of transforming growth factor beta1 production|regulation of MAPK cascade|eye pigmentation|head morphogenesis|,aspartic-type endopeptidase activity|receptor activity|enzyme binding|,4,6,3.99E+08,15.70%
1871,Q9DBH5,0.000379979,-0.193166667,47.72295633,1.358333333,1.69E-05,9.489782533,-1.102,-0.933,-0.582,0.577,0.345,0.536,Q9DBH5,Lman2,Q9DBH5_Lman2,Q9DBH5,Lman2,1,9,6,6,Q9DBH5,MOUSE,40771.4,18.7,1408,1408.1,77.8,77.8,NA,358,Vesicular integral-membrane protein VIP36,Golgi membrane|extracellular space|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|integral component of plasma membrane|cell surface|extracellular exosome|,"retrograde vesicle-mediated transport, Golgi to ER|protein transport|positive regulation of phagocytosis|",glycoprotein binding|mannose binding|carbohydrate binding|heat shock protein binding|metal ion binding|,6,9,1.86E+09,18.70%
1473,Q0VBD0,0.00013371,-0.181666667,53.21376593,1.354,4.77E-06,11.31331651,-0.78,-1.095,-0.701,0.448,0.447,0.591,Q0VBD0,Itgb8,Q0VBD0_Itgb8,Q0VBD0,Itgb8,1,15,11,11,Q0VBD0,MOUSE,87598.2,16.9,1050,1050.1,117.25,117.25,NA,767,Integrin beta,cell surface|integrin alphav-beta8 complex|extracellular exosome|,ganglioside metabolic process|cell-matrix adhesion|integrin-mediated signaling pathway|positive regulation of gene expression|negative regulation of gene expression|cartilage development|,receptor activity|extracellular matrix protein binding|,11,15,9.67E+08,16.90%
2812,Q8CI59-2,6.81E-05,-0.169,57.19313006,1.349333333,1.91E-06,12.82470723,-0.789,-0.764,-0.978,0.648,0.487,0.382,Q8CI59,Steap3,Q8CI59-2_Steap3,Q8CI59-2,Steap3,1,2,2,2,Q8CI59-2|E9QN92|Q8CI59|A0A0R4J1G9,MOUSE,59099.6,5.5,2325,2325.1,30.57,30.57,NA,488,Isoform 2 of Metalloreductase STEAP3,endosome|multivesicular body|plasma membrane|integral component of plasma membrane|endosome membrane|,iron ion transport|apoptotic process|cell cycle|protein secretion|copper ion import|iron ion homeostasis|oxidation-reduction process|ferric iron import into cell|positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator|exosomal secretion|,ferric-chelate reductase activity|cupric reductase activity|metal ion binding|ferric-chelate reductase (NADPH) activity|,2,2,26600000,5.50%
1537,Q8BQ47,4.74E-05,-0.004166667,59.71288055,1.343666667,1.07E-06,13.87530783,-0.723,-0.657,-0.648,0.774,0.506,0.723,Q8BQ47,Cnpy4,Q8BQ47_Cnpy4,Q8BQ47,Cnpy4,1,19,7,7,Q8BQ47,MOUSE,28492.6,32.6,1105,1105.1,110.61,110.61,NA,245,Protein canopy homolog 4,extracellular region|,regulation of protein localization|,receptor binding|,7,19,3.99E+09,32.60%
669,P70663,5.01E-05,-0.095166667,59.31141562,1.343,1.17E-06,13.70274129,-0.868,-0.717,-0.715,0.629,0.434,0.666,P70663,Sparcl1,P70663_Sparcl1,P70663,Sparcl1,1,50,22,22,P70663,MOUSE,73141.8,40.7,387,387.1,291.87,291.87,NA,650,SPARC-like protein 1,proteinaceous extracellular matrix|extracellular space|extracellular exosome|,signal transduction|,calcium ion binding|,22,50,1.10E+10,40.70%
1688,Q60715,0.000330517,-0.139833333,48.41518687,1.342333333,1.44E-05,9.704468923,-1.095,-0.738,-0.6,0.504,0.435,0.655,Q60715,P4ha1,Q60715_P4ha1,Q60715,P4ha1,1,12,9,9,Q60715|Q60715-2|E9Q7B0,MOUSE,61194.2,21.7,1237,1237.1,95.4,95.4,NA,534,Prolyl 4-hydroxylase subunit alpha-1,mitochondrion|endoplasmic reticulum|endoplasmic reticulum lumen|membrane|procollagen-proline 4-dioxygenase complex|intracellular membrane-bounded organelle|,peptidyl-proline hydroxylation to 4-hydroxy-L-proline|collagen fibril organization|oxidation-reduction process|,"procollagen-proline 4-dioxygenase activity|iron ion binding|oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen|L-ascorbic acid binding|procollagen-proline 4-dioxygenase activity|",9,12,9.54E+08,21.70%
3189,Q9WUU7,0.000783925,0.086,43.72452801,1.336666667,4.24E-05,8.327097579,-0.455,-0.665,-0.627,0.682,0.475,1.106,Q9WUU7,Ctsz,Q9WUU7_Ctsz,Q9WUU7,Ctsz,1,3,2,2,Q9WUU7,MOUSE,34680.3,7.1,2716,2716.1,20.49,20.49,NA,306,Cathepsin Z,extracellular space|lysosome|endoplasmic reticulum|intracellular membrane-bounded organelle|extracellular exosome|,proteolysis involved in cellular protein catabolic process|epithelial tube branching involved in lung morphogenesis|,cysteine-type endopeptidase activity|,2,3,75400000,7.10%
2351,Q3TAA8,5.16E-05,-0.173166667,59.02135645,1.335,1.25E-06,13.57930615,-0.704,-0.989,-0.829,0.557,0.448,0.478,Q3TAA8,Pigu,Q3TAA8_Pigu,Q3TAA8,Pigu,1,4,3,3,Q3TAA8|Q8K358,MOUSE,50292.9,8.7,1868,1868.1,48.42,48.42,NA,435,Phosphatidylinositol glycan anchor biosynthesis class U protein,plasma membrane|membrane|GPI-anchor transamidase complex|,GPI anchor biosynthetic process|attachment of GPI anchor to protein|regulation of JAK-STAT cascade|,GPI-anchor transamidase activity|GPI anchor binding|,3,4,3.42E+08,8.70%
397,P83093,0.000110941,-0.137833333,54.39590779,1.334333333,3.63E-06,11.74444593,-0.818,-0.876,-0.721,0.434,0.406,0.748,P83093,Stim2,P83093_Stim2,P83093,Stim2,1,89,32,31,P83093|I1E4X8,MOUSE,84779.2,44.6,218,218.1,431.11,411.95,NA,746,Stromal interaction molecule 2,endoplasmic reticulum|endoplasmic reticulum membrane|plasma membrane|integral component of membrane|,cellular calcium ion homeostasis|activation of store-operated calcium channel activity|positive regulation of calcium ion transport|calcium ion transmembrane transport|,calcium channel regulator activity|calcium ion binding|protein binding|store-operated calcium channel activity|,32,89,2.09E+10,44.60%
354,E9QM38,0.000807623,-0.009166667,43.50228414,1.333,4.46E-05,8.266135802,-0.587,-0.698,-0.742,0.521,0.414,1.037,E9QM38,Slc12a2,E9QM38_Slc12a2,E9QM38,Slc12a2,1,103,34,34,E9QM38|P55012|P55014|P55014-4|P55014-3|A2AQ50|A2AQ51|A2AQ52|P55014-2,MOUSE,131407.2,30.9,189,189.1,477.66,477.66,NA,1206,Solute carrier family 12 member 2,integral component of membrane|basolateral plasma membrane|apical plasma membrane|extracellular exosome|extracellular vesicle|,ammonium transport|transepithelial chloride transport|multicellular organism growth|detection of mechanical stimulus involved in sensory perception of sound|branching involved in mammary gland duct morphogenesis|mammary duct terminal end bud growth|transepithelial ammonium transport|ammonium transmembrane transport|chloride transmembrane transport|,protein binding|ammonium transmembrane transporter activity|cation:chloride symporter activity|,34,103,3.33E+10,30.90%
2778,Q2TA57,0.000261249,-0.2255,49.67624743,1.327666667,1.08E-05,10.10641582,-1.174,-0.723,-0.771,0.467,0.352,0.496,Q2TA57,Asphd1,Q2TA57_Asphd1,Q2TA57,Asphd1,1,5,3,3,Q2TA57|Q2TA57-2,MOUSE,38949.7,10.8,2292,2292.1,31.54,31.54,NA,360,Aspartate beta-hydroxylase domain-containing protein 1,integral component of membrane|,peptidyl-amino acid modification|oxidation-reduction process|,dioxygenase activity|,3,5,1.13E+08,10.80%
2899,O70472,0.000104533,-0.094166667,54.74145369,1.326333333,3.36E-06,11.87324392,-0.897,-0.696,-0.679,0.627,0.39,0.69,O70472,Tmem131,O70472_Tmem131,O70472,Tmem131,1,5,4,4,O70472,MOUSE,205388.7,2.6,2412,2412.1,27.52,27.52,NA,1877,Transmembrane protein 131,integral component of membrane|,,,4,5,87200000,2.60%
2627,P07724,0.001109652,-0.1105,41.76958621,1.322333333,6.65E-05,7.862430743,-0.84,-0.623,-0.852,0.377,0.938,0.337,P07724,Alb,P07724_Alb,P07724,Alb,1,5,3,3,P07724,MOUSE,70745.2,7,2143,2143.1,36.99,36.99,NA,608,Serum albumin,extracellular region|extracellular space|nucleus|cytoplasm|myelin sheath|protein complex|extracellular exosome|blood microparticle|,retina homeostasis|transport|cellular response to starvation|hemolysis by symbiont of host erythrocytes|negative regulation of apoptotic process|maintenance of mitochondrion location|,DNA binding|fatty acid binding|drug binding|toxic substance binding|pyridoxal phosphate binding|metal ion binding|chaperone binding|oxygen binding|,3,5,47200000,7.00%
2091,Q5FWH7,5.01E-05,-0.14,59.35141769,1.322,1.16E-06,13.71984584,-0.728,-0.9,-0.775,0.459,0.449,0.655,Q5FWH7,Slc39a12,Q5FWH7_Slc39a12,Q5FWH7,Slc39a12,1,9,6,6,Q5FWH7|Q5FWH7-2,MOUSE,77012.8,10.8,1613,1613.1,61.38,61.38,NA,689,Zinc transporter ZIP12,plasma membrane|integral component of membrane|perinuclear region of cytoplasm|extracellular vesicle|,signal transduction|regulation of neuron projection development|regulation of microtubule polymerization|zinc II ion transmembrane import|,zinc ion transmembrane transporter activity|,6,9,1.08E+09,10.80%
543,Q6P8S1,2.38E-05,-0.139666667,64.08263072,1.304666667,3.91E-07,15.89004078,-0.833,-0.744,-0.799,0.579,0.441,0.518,Q6P8S1,Asph,Q6P8S1_Asph,Q6P8S1,Asph,1,4,4,2,Q6P8S1|A2AL79,MOUSE,22545.2,32.5,319,319.2,55.89,25.68,NA,212,Aspartyl/asparaginyl beta-hydroxylase,endoplasmic reticulum|plasma membrane|integral component of membrane|integral component of endoplasmic reticulum membrane|cortical endoplasmic reticulum|,"pattern specification process|negative regulation of cell proliferation|positive regulation of calcium ion transport into cytosol|regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity|activation of store-operated calcium channel activity|response to ATP|limb morphogenesis|peptidyl-aspartic acid hydroxylation|positive regulation of proteolysis|positive regulation of transcription, DNA-templated|oxidation-reduction process|palate development|face morphogenesis|calcium ion transmembrane transport|cellular response to calcium ion|positive regulation of intracellular protein transport|activation of cysteine-type endopeptidase activity|",peptide-aspartate beta-dioxygenase activity|calcium ion binding|,2,4,2.32E+09,8.00%
1181,Q8BRH0,0.001353484,0.106166667,40.76110008,1.295,8.39E-05,7.608542304,-0.601,-0.425,-0.598,1.006,0.353,0.902,Q8BRH0,Tmtc3,Q8BRH0_Tmtc3,Q8BRH0,Tmtc3,1,19,13,13,G5E8C4|Q8BRH0|A0A0R4J173|Q8BRH0-2,MOUSE,105108.6,17.8,800,800.1,161.37,161.37,NA,920,Transmembrane and TPR repeat-containing protein 3,integral component of membrane|,post-embryonic development|regulation of gene expression|cell differentiation|lung development|lung alveolus development|muscle fiber development|bud outgrowth involved in lung branching|,,13,19,2.31E+09,17.80%
2357,Q8BXZ1,0.000121745,-0.095833333,53.76567096,1.284333333,4.20E-06,11.51278663,-0.552,-0.798,-0.864,0.499,0.466,0.674,Q8BXZ1,Tmx3,Q8BXZ1_Tmx3,Q8BXZ1,Tmx3,1,9,4,4,Q8BXZ1,MOUSE,52189.4,10.3,1874,1874.1,48.24,48.24,NA,456,Protein disulfide-isomerase TMX3,endoplasmic reticulum membrane|cell surface|integral component of membrane|,protein folding|response to endoplasmic reticulum stress|cell redox homeostasis|,protein disulfide isomerase activity|,4,9,7.22E+08,10.30%
1070,P43406,5.43E-05,-0.172666667,58.49526572,1.282666667,1.41E-06,13.35805776,-0.825,-0.87,-0.747,0.369,0.42,0.617,P43406,Itgav,P43406_Itgav,P43406,Itgav,1,21,17,17,P43406|A2AKI5,MOUSE,116441.9,19.7,703,703.1,179.53,179.53,NA,1044,Integrin alpha-V,intracellular|plasma membrane|focal adhesion|integrin complex|external side of plasma membrane|cell surface|membrane|lamellipodium membrane|filopodium membrane|microvillus membrane|ruffle membrane|integrin alphav-beta3 complex|integrin alphav-beta5 complex|integrin alphav-beta8 complex|alphav-beta3 integrin-IGF-1-IGF1R complex|extracellular exosome|,angiogenesis|blood vessel development|inflammatory response|cell adhesion|cell-matrix adhesion|integrin-mediated signaling pathway|positive regulation of cell proliferation|fertilization|negative regulation of macrophage derived foam cell differentiation|negative regulation of lipid storage|cell growth|cell migration|positive regulation of cell migration|cell-substrate adhesion|negative regulation of lipid transport|detection of molecule of bacterial origin|positive regulation of osteoblast proliferation|heterotypic cell-cell adhesion|substrate adhesion-dependent cell spreading|gonad morphogenesis|endodermal cell differentiation|apolipoprotein A-I-mediated signaling pathway|T cell activation|apoptotic cell clearance|endothelial cell migration|regulation of bone resorption|negative regulation of low-density lipoprotein particle receptor biosynthetic process|positive regulation of cell adhesion|viral entry into host cell|focal adhesion assembly|negative regulation of lipoprotein metabolic process|regulation of phagocytosis|negative chemotaxis|release of sequestered calcium ion into cytosol|trophoblast giant cell differentiation|ERK1 and ERK2 cascade|calcium ion transmembrane transport|response to nitric oxide|extrinsic apoptotic signaling pathway in absence of ligand|regulation of apoptotic cell clearance|negative regulation of entry of bacterium into host cell|negative regulation of extrinsic apoptotic signaling pathway|,fibronectin binding|protease binding|voltage-gated calcium channel activity|metal ion binding|protein heterodimerization activity|transforming growth factor beta binding|extracellular matrix binding|extracellular matrix protein binding|opsonin binding|protein kinase C binding|insulin-like growth factor I binding|,17,21,3.84E+09,19.70%
2480,Q9CQF9,6.53E-05,-0.1145,57.50818321,1.282333333,1.77E-06,12.95191788,-0.704,-0.78,-0.783,0.683,0.385,0.512,Q9CQF9,Pcyox1,Q9CQF9_Pcyox1,Q9CQF9,Pcyox1,1,10,4,4,Q9CQF9|A0A0N4SWD3,MOUSE,56721.9,10.8,1996,1996.1,42.74,42.74,NA,505,Prenylcysteine oxidase,lysosome|vacuolar membrane|plasma membrane|very-low-density lipoprotein particle|extracellular exosome|,prenylated protein catabolic process|prenylcysteine catabolic process|oxidation-reduction process|chloride transmembrane transport|,prenylcysteine oxidase activity|chloride-transporting ATPase activity|,4,10,5.66E+08,10.80%
1602,Q9QY81,0.000244632,-0.0085,50.16920963,1.277666667,9.62E-06,10.26745097,-0.664,-0.531,-0.747,0.853,0.43,0.608,Q9QY81,Nup210,Q9QY81_Nup210,Q9QY81,Nup210,1,14,8,8,Q9QY81|A0A0R4J1I6,MOUSE,205066.8,5.9,1160,1160.1,104.74,104.74,NA,1886,Nuclear pore membrane glycoprotein 210,nuclear envelope|nuclear pore|endoplasmic reticulum membrane|membrane|nuclear membrane|,protein transport|mRNA transport|,protein dimerization activity|,8,14,6.34E+08,5.90%
2219,P06728,0.000342287,-0.115666667,48.2341723,1.276,1.50E-05,9.647928558,-0.593,-0.757,-0.911,0.453,0.756,0.358,P06728,Apoa4,P06728_Apoa4,P06728,Apoa4,1,5,4,4,P06728,MOUSE,45028.2,12.1,1738,1738.1,54.4,54.4,NA,395,Apolipoprotein A-IV,extracellular region|extracellular space|cytosol|very-low-density lipoprotein particle|high-density lipoprotein particle|chylomicron|extracellular exosome|blood microparticle|cell surface|,innate immune response in mucosa|cholesterol biosynthetic process|lipid transport|response to lipid hydroperoxide|leukocyte cell-cell adhesion|cholesterol metabolic process|positive regulation of cholesterol esterification|positive regulation of triglyceride catabolic process|removal of superoxide radicals|triglyceride catabolic process|regulation of intestinal cholesterol absorption|neuron projection regeneration|regulation of cholesterol transport|cholesterol efflux|phospholipid efflux|very-low-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|negative regulation of plasma lipoprotein particle oxidation|response to stilbenoid|lipoprotein metabolic process|cholesterol homeostasis|hydrogen peroxide catabolic process|reverse cholesterol transport|multicellular organismal lipid catabolic process|positive regulation of fatty acid biosynthetic process|phosphatidylcholine metabolic process|positive regulation of lipoprotein lipase activity|lipid homeostasis|protein-lipid complex assembly|triglyceride homeostasis|,copper ion binding|lipid binding|cholesterol binding|antioxidant activity|cholesterol transporter activity|phosphatidylcholine binding|protein homodimerization activity|phosphatidylcholine-sterol O-acyltransferase activator activity|,4,5,6.30E+07,12.10%
2999,Q8BWP8,7.11E-05,-0.183333333,56.77807196,1.274666667,2.10E-06,12.65887232,-0.8,-0.925,-0.737,0.6,0.415,0.347,Q8BWP8,B4gat1,Q8BWP8_B4gat1,Q8BWP8,B4gat1,1,5,2,2,Q8BWP8|Q8BWP8-2,MOUSE,47839.9,6,2511,2511.1,24.92,24.92,NA,415,"Beta-1,4-glucuronyltransferase 1",Golgi membrane|Golgi apparatus|integral component of membrane|extracellular exosome|,protein glycosylation|axon guidance|protein O-linked mannosylation|poly-N-acetyllactosamine biosynthetic process|,"glucuronosyltransferase activity|metal ion binding|N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity|",2,5,1.25E+08,6.00%
1970,Q8C0L0,3.04E-05,-0.218666667,62.6536497,1.269333333,5.43E-07,15.20272453,-0.78,-0.873,-0.907,0.36,0.482,0.406,Q8C0L0,Tmx4,Q8C0L0_Tmx4,Q8C0L0,Tmx4,1,7,5,5,Q8C0L0|A2ARI0,MOUSE,37530,18.2,1500,1500.1,70.96,70.96,NA,335,Thioredoxin-related transmembrane protein 4,cell|integral component of membrane|,protein folding|response to endoplasmic reticulum stress|cell redox homeostasis|oxidation-reduction process|,protein disulfide isomerase activity|,5,7,1.25E+09,18.20%
1533,Q8K2C7,5.16E-05,-0.1,59.06446043,1.265333333,1.24E-06,13.59758352,-0.612,-0.739,-0.847,0.595,0.469,0.534,Q8K2C7,Os9,Q8K2C7_Os9,Q8K2C7,Os9,1,14,10,10,Q8K2C7|Q8K2C7-2,MOUSE,76562.9,13.9,1101,1101.1,111.12,111.12,NA,672,Protein OS-9,endoplasmic reticulum lumen|,"protein targeting|protein retention in ER lumen|protein ubiquitination|ER-associated ubiquitin-dependent protein catabolic process|response to endoplasmic reticulum stress|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|negative regulation of retrograde protein transport, ER to cytosol|",glycoprotein binding|protease binding|carbohydrate binding|,10,14,5.18E+08,13.90%
1292,Q60841,9.43E-05,-0.131333333,55.42221717,1.254666667,2.87E-06,12.13075223,-0.741,-0.825,-0.71,0.407,0.399,0.682,Q60841,Reln,Q60841_Reln,Q60841,Reln,1,15,14,14,Q60841|Q60841-2|Q60841-3,MOUSE,394505.8,5.5,885,885.1,143.12,143.12,NA,3461,Reelin,proteinaceous extracellular matrix|extracellular space|cytoplasm|dendrite|,"cell morphogenesis involved in differentiation|neuron migration|proteolysis|cell adhesion|axon guidance|central nervous system development|brain development|learning|long-term memory|associative learning|glial cell differentiation|regulation of gene expression|positive regulation of neuron projection development|positive regulation of phosphatidylinositol 3-kinase signaling|dendrite development|cell migration|peptidyl-tyrosine phosphorylation|spinal cord patterning|ventral spinal cord development|hippocampus development|cerebral cortex tangential migration|layer formation in cerebral cortex|cerebral cortex development|forebrain development|positive regulation of TOR signaling|positive regulation of CREB transcription factor activity|protein localization to synapse|reelin-mediated signaling pathway|positive regulation of protein kinase activity|response to pain|positive regulation of peptidyl-tyrosine phosphorylation|regulation of behavior|regulation of synaptic transmission|positive regulation of small GTPase mediated signal transduction|positive regulation of synaptic transmission, glutamatergic|long-term synaptic potentiation|positive regulation of dendritic spine morphogenesis|positive regulation of protein tyrosine kinase activity|positive regulation of synapse maturation|postsynaptic density assembly|N-methyl-D-aspartate receptor clustering|postsynaptic density protein 95 clustering|receptor localization to synapse|lateral motor column neuron migration|positive regulation of long-term synaptic potentiation|positive regulation of lateral motor column neuron migration|regulation of N-methyl-D-aspartate selective glutamate receptor activity|positive regulation of excitatory postsynaptic membrane potential|positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity|",protein binding|serine-type peptidase activity|metal ion binding|lipoprotein particle receptor binding|very-low-density lipoprotein particle receptor binding|,14,15,3.47E+08,5.50%
1139,Q06335,4.55E-05,-0.097666667,60.00930539,1.247333333,9.98E-07,14.00402055,-0.674,-0.771,-0.719,0.556,0.408,0.614,Q06335,Aplp2,Q06335_Aplp2,Q06335,Aplp2,1,26,13,1,Q06335|Q06335-2,MOUSE,81150.4,21.2,761,761.1,168.79,14.37,NA,707,Amyloid-like protein 2,nucleus|plasma membrane|membrane|integral component of membrane|extracellular exosome|,suckling behavior|cellular copper ion homeostasis|regulation of epidermal growth factor-activated receptor activity|mating behavior|locomotory behavior|cholesterol metabolic process|extracellular matrix organization|forebrain development|midbrain development|regulation of protein binding|neuromuscular process controlling balance|,DNA binding|protein binding|heparin binding|identical protein binding|transition metal ion binding|,13,26,3.18E+09,21.20%
3181,Q0V8T9,7.06E-05,-0.165166667,56.94079491,1.242333333,2.02E-06,12.72365124,-0.896,-0.72,-0.743,0.582,0.435,0.351,Q0V8T9,Cntnap5a,Q0V8T9_Cntnap5a,Q0V8T9,Cntnap5a,1,2,2,2,Q0V8T9,MOUSE,147762,1.5,2707,2707.1,20.6,20.6,NA,1304,Contactin-associated protein like 5-1,integral component of membrane|,proteolysis|cell adhesion|,aspartic-type endopeptidase activity|,2,2,1.19E+08,1.50%
891,Q07113,0.000806837,-0.103,43.52955403,1.242,4.44E-05,8.273596169,-0.938,-0.659,-0.575,0.412,0.341,0.801,Q07113,Igf2r,Q07113_Igf2r,Q07113,Igf2r,1,25,21,21,Q07113,MOUSE,280828.2,10.5,556,556.1,218.58,218.58,NA,2483,Cation-independent mannose-6-phosphate receptor,nucleus|nuclear envelope lumen|lysosomal membrane|endosome|early endosome|late endosome|trans-Golgi network|focal adhesion|cell surface|membrane|integral component of membrane|endocytic vesicle|trans-Golgi network transport vesicle|extracellular exosome|,transport|,glycoprotein binding|transporter activity|insulin-like growth factor binding|mannose binding|identical protein binding|phosphoprotein binding|,21,25,2.60E+09,10.50%
946,O08807,0.00039871,-0.0935,47.4855041,1.235,1.78E-05,9.417088649,-0.92,-0.445,-0.768,0.46,0.486,0.626,O08807,Prdx4,O08807_Prdx4,O08807,Prdx4,1,22,9,7,O08807,MOUSE,31280.1,29.5,601,601.2,129.35,100.05,NA,274,Peroxiredoxin-4,extracellular space|nucleus|cytoplasm|mitochondrion|endoplasmic reticulum|smooth endoplasmic reticulum|cytosol|extracellular exosome|,spermatogenesis|male gonad development|4-hydroxyproline metabolic process|protein maturation by protein folding|extracellular matrix organization|cell redox homeostasis|oxidation-reduction process|reactive oxygen species metabolic process|negative regulation of male germ cell proliferation|,peroxidase activity|protein homodimerization activity|peroxiredoxin activity|,7,22,5.54E+09,25.50%
2567,Q8CF93-2,0.000463263,-0.060333333,46.6395178,1.232,2.17E-05,9.161961037,-0.609,-0.836,-0.584,0.8,0.345,0.522,Q8CF93,Galnt13,Q8CF93-2_Galnt13,Q8CF93-2,Galnt13,1,7,5,5,Q8CF93-2|Q8CF93|O08912,MOUSE,68878.7,6.7,2083,2083.1,39.13,39.13,NA,556,Isoform 2 of Polypeptide N-acetylgalactosaminyltransferase 13,Golgi membrane|integral component of membrane|,protein O-linked glycosylation|,polypeptide N-acetylgalactosaminyltransferase activity|carbohydrate binding|metal ion binding|,5,7,8.42E+08,6.70%
1517,Q61029,0.000420237,-0.013833333,47.20073554,1.224333333,1.91E-05,9.330540019,-0.473,-0.663,-0.742,0.85,0.455,0.49,Q61029,Tmpo,Q61029_Tmpo,Q61029,Tmpo,1,17,9,3,Q61029|Q61029-3|Q61029-2|Q61029-4|Q61033-2,MOUSE,50428.9,31.6,1087,1087.1,112.88,35.62,NA,452,"Lamina-associated polypeptide 2, isoforms beta/delta/epsilon/gamma",chromatin|nucleus|nuclear envelope|nuclear inner membrane|membrane|integral component of membrane|nuclear membrane|,"regulation of transcription, DNA-templated|",DNA binding|protein binding|,9,17,1.48E+09,31.60%
1478,P08226,5.43E-05,-0.098666667,58.64178421,1.218666667,1.37E-06,13.41933805,-0.603,-0.749,-0.772,0.437,0.493,0.602,P08226,Apoe,P08226_Apoe,P08226,Apoe,1,16,10,10,P08226,MOUSE,35923,29.9,1055,1055.1,116.81,116.81,NA,311,Apolipoprotein E,extracellular region|extracellular space|nucleus|endoplasmic reticulum|Golgi apparatus|cytosol|membrane|extracellular matrix|very-low-density lipoprotein particle|low-density lipoprotein particle|intermediate-density lipoprotein particle|high-density lipoprotein particle|chylomicron|extracellular exosome|blood microparticle|extracellular vesicle|,negative regulation of endothelial cell proliferation|response to dietary excess|lipid metabolic process|triglyceride metabolic process|cholesterol biosynthetic process|cholesterol catabolic process|cellular calcium ion homeostasis|receptor-mediated endocytosis|response to oxidative stress|G-protein coupled receptor signaling pathway|nitric oxide mediated signal transduction|cholesterol metabolic process|regulation of gene expression|negative regulation of platelet activation|positive regulation of cholesterol esterification|positive regulation of cholesterol efflux|long-chain fatty acid transport|protein import|virion assembly|triglyceride catabolic process|cGMP-mediated signaling|negative regulation of blood coagulation|regulation of axon extension|positive regulation of cGMP biosynthetic process|regulation of cholesterol transport|regulation of Cdc42 protein signal transduction|positive regulation of low-density lipoprotein particle receptor catabolic process|cholesterol efflux|phospholipid efflux|very-low-density lipoprotein particle remodeling|low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|chylomicron remnant clearance|high-density lipoprotein particle clearance|very-low-density lipoprotein particle clearance|lipoprotein metabolic process|lipoprotein biosynthetic process|lipoprotein catabolic process|vasodilation|cholesterol homeostasis|negative regulation of MAP kinase activity|negative regulation of neuron apoptotic process|negative regulation of blood vessel endothelial cell migration|reverse cholesterol transport|positive regulation by host of viral process|negative regulation of cholesterol biosynthetic process|positive regulation of lipid biosynthetic process|artery morphogenesis|negative regulation of inflammatory response|positive regulation of nitric-oxide synthase activity|positive regulation of membrane protein ectodomain proteolysis|negative regulation of lipid biosynthetic process|maintenance of location in cell|lipid homeostasis|fatty acid homeostasis|positive regulation of dendritic spine development|negative regulation of dendritic spine development|cardiovascular system development|negative regulation of cholesterol efflux|alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor clustering|N-methyl-D-aspartate receptor clustering|regulation of beta-amyloid clearance|regulation of neuron death|negative regulation of neuron death|positive regulation of neuron death|negative regulation of postsynaptic membrane organization|positive regulation of postsynaptic membrane organization|negative regulation of presynaptic membrane organization|positive regulation of presynaptic membrane organization|positive regulation of beta-amyloid formation|negative regulation of beta-amyloid formation|regulation of tau-protein kinase activity|negative regulation of dendritic spine maintenance|positive regulation of dendritic spine maintenance|positive regulation of phospholipid efflux|positive regulation of neurofibrillary tangle assembly|negative regulation of phospholipid efflux|negative regulation of lipid transport across blood brain barrier|positive regulation of lipid transport across blood brain barrier|protein localization|axon regeneration|,beta-amyloid binding|lipid transporter activity|protein binding|phospholipid binding|heparin binding|lipid binding|cholesterol binding|antioxidant activity|cholesterol transporter activity|identical protein binding|protein homodimerization activity|metal chelating activity|tau protein binding|low-density lipoprotein particle receptor binding|phosphatidylcholine-sterol O-acyltransferase activator activity|very-low-density lipoprotein particle receptor binding|lipoprotein particle binding|,10,16,1.18E+09,29.90%
1748,P97467,0.000422894,-0.049,47.117676,1.217333333,1.94E-05,9.305424763,-0.609,-0.774,-0.59,0.82,0.502,0.357,P97467,Pam,P97467_Pam,P97467,Pam,1,9,6,6,P97467|F8VQA4|E9Q704,MOUSE,109816.4,12,1291,1291.1,89.89,89.89,NA,979,Peptidyl-glycine alpha-amidating monooxygenase,cytosol|integral component of plasma membrane|membrane|transport vesicle membrane|extracellular exosome|,peptide amidation|peptide metabolic process|oxidation-reduction process|,peptidylglycine monooxygenase activity|peptidylamidoglycolate lyase activity|copper ion binding|zinc ion binding|L-ascorbic acid binding|,6,9,6.78E+08,12.00%
3172,Q09200,0.000776884,-0.101333333,43.8129502,1.208,4.16E-05,8.351454513,-0.903,-0.665,-0.548,0.758,0.294,0.456,Q09200,B4galnt1,Q09200_B4galnt1,Q09200,B4galnt1,1,2,2,2,Q09200,MOUSE,59610.2,4.6,2698,2698.1,20.85,20.85,NA,533,"Beta-1,4 N-acetylgalactosaminyltransferase 1",plasma membrane|integral component of Golgi membrane|,ganglioside biosynthetic process|protein glycosylation|glycosphingolipid metabolic process|spermatogenesis|lipid storage|lipid glycosylation|,(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity|,2,2,82800000,4.60%
3306,Q9Z247,0.001353484,0.021833333,40.77322367,1.199,8.37E-05,7.546617881,-0.353,-0.718,-0.662,0.57,0.378,0.916,Q9Z247,Fkbp9,Q9Z247_Fkbp9,Q9Z247,Fkbp9,1,4,2,2,Q9Z247,MOUSE,63450.7,2.9,2853,2853.1,17.98,17.98,NA,570,Peptidyl-prolyl cis-trans isomerase FKBP9,cytoplasm|endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum membrane|,protein peptidyl-prolyl isomerization|protein folding|chaperone-mediated protein folding|,peptidyl-prolyl cis-trans isomerase activity|calcium ion binding|FK506 binding|,2,4,9.52E+08,2.90%
1763,Q9Z2G6,0.000146133,-0.168666667,52.6878165,1.19,5.39E-06,11.12612519,-0.954,-0.719,-0.618,0.499,0.381,0.399,Q9Z2G6,Sel1l,Q9Z2G6_Sel1l,Q9Z2G6,Sel1l,1,12,7,7,Q9Z2G6|Q9Z2G6-2|J3QJX3,MOUSE,88852.3,12.4,1305,1305.1,88.59,88.59,NA,790,Protein sel-1 homolog 1,endoplasmic reticulum membrane|integral component of membrane|,"Notch signaling pathway|retrograde protein transport, ER to cytosol|response to endoplasmic reticulum stress|",,7,12,2.43E+09,12.40%
3192,Q9D074-5,0.011022976,-0.137166667,30.49767473,1.184333333,0.000891728,5.3139799,-1.17,-0.697,-0.321,0.456,0.195,0.714,Q9D074,Mgrn1,Q9D074-5_Mgrn1,Q9D074-5,Mgrn1,1,4,2,2,Q9D074-5|Q9D074-4|Q9D074-3|Q9D074-2|Q9D074|A2AAN9|Q3TEL6-2|Q3TEL6|A2AAP0,MOUSE,64194.7,2.9,2719,2719.1,20.44,20.44,NA,532,Isoform 5 of E3 ubiquitin-protein ligase MGRN1,nucleus|cytoplasm|early endosome|plasma membrane|membrane|extracellular exosome|,protein polyubiquitination|protein monoubiquitination|endosome to lysosome transport|negative regulation of cAMP-mediated signaling|negative regulation of G-protein coupled receptor protein signaling pathway|,ubiquitin-protein transferase activity|zinc ion binding|ligase activity|ubiquitin protein ligase activity|,2,4,1.98E+08,2.90%
3039,Q8R0F3,0.02309374,0.116333333,26.6934556,1.181333333,0.002141186,4.580558873,-0.056,-0.29,-1.077,0.728,0.459,0.934,Q8R0F3,Sumf1,Q8R0F3_Sumf1,Q8R0F3,Sumf1,1,3,3,3,Q8R0F3|E9Q265|E9Q0Z7,MOUSE,41286.3,11,2555,2555.1,23.96,23.96,NA,372,Sulfatase-modifying factor 1,endoplasmic reticulum|endoplasmic reticulum lumen|,oxidation-reduction process|,protein binding|oxidoreductase activity|protein homodimerization activity|metal ion binding|,3,3,19800000,11.00%
2036,Q60751,0.000104533,-0.142666667,54.78512973,1.18,3.32E-06,11.88961454,-0.861,-0.707,-0.63,0.409,0.368,0.565,Q60751,Igf1r,Q60751_Igf1r,Q60751,Igf1r,1,15,6,5,Q60751|E9QNX9|Q9WTL4,MOUSE,158295.8,5.7,1561,1561.1,66.06,57.73,NA,1373,Insulin-like growth factor 1 receptor,plasma membrane|membrane|integral component of membrane|intracellular membrane-bounded organelle|receptor complex|,"protein phosphorylation|immune response|brain development|epidermis development|organ morphogenesis|male sex determination|adrenal gland development|positive regulation of cell migration|mammary gland development|exocrine pancreas development|peptidyl-tyrosine autophosphorylation|negative regulation of apoptotic process|negative regulation of MAPK cascade|positive regulation of MAPK cascade|negative regulation of sequence-specific DNA binding transcription factor activity|positive regulation of DNA replication|positive regulation of mitotic nuclear division|positive regulation of transcription, DNA-templated|regulation of JNK cascade|protein autophosphorylation|insulin-like growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|protein tetramerization|inactivation of MAPKK activity|positive regulation of meiotic cell cycle|positive regulation of protein kinase B signaling|negative regulation of protein kinase B signaling|prostate gland epithelium morphogenesis|",protein tyrosine kinase activity|insulin-like growth factor-activated receptor activity|insulin receptor binding|protein binding|insulin-like growth factor binding|ATP binding|insulin-like growth factor I binding|identical protein binding|phosphatidylinositol 3-kinase binding|insulin binding|insulin receptor substrate binding|,7,15,8.20E+08,5.70%
1413,E9PYH0,0.000519439,0.0065,45.90477585,1.174333333,2.57E-05,8.945180309,-0.622,-0.601,-0.519,0.802,0.312,0.667,E9PYH0,Vcan,E9PYH0_Vcan,E9PYH0,Vcan,1,16,10,10,E9PYH0|G3XA35|Q62059|Q62059-2|E9QMK2|Q62059-3|E9QMK3|Q62059-4|Q8BS97,MOUSE,368941.5,3.5,997,997.1,125.43,125.43,NA,3354,Versican core protein,extracellular region|proteinaceous extracellular matrix|extracellular space|membrane|extracellular matrix|intracellular membrane-bounded organelle|extracellular matrix|,skeletal system development|osteoblast differentiation|cell adhesion|central nervous system development|heart development|glial cell migration|regulation of phosphoprotein phosphatase activity|,calcium ion binding|hyaluronic acid binding|protein phosphatase binding|,10,16,1.63E+09,3.50%
2599,Q60673,0.002507972,-0.005166667,37.7250562,1.167666667,0.000168847,6.855407923,-0.631,-0.562,-0.574,0.943,0.577,0.216,Q60673,NotFound,Q60673_NotFound,Q60673,Ptprn,1,4,3,3,Q60673|A6MDD2,MOUSE,107051.4,3.6,2115,2115.1,37.82,37.82,NA,979,Receptor-type tyrosine-protein phosphatase-like N,cell|integral component of membrane|,response to reactive oxygen species|protein dephosphorylation|insulin secretion|dense core granule maturation|,protein binding|spectrin binding|protein tyrosine phosphatase activity|,3,4,59900000,3.60%
2621,A2ACD2,0.001138002,0.015166667,41.59692587,1.160333333,6.92E-05,7.758260721,-0.596,-0.322,-0.777,0.831,0.429,0.526,A2ACD2,Vstm2l,A2ACD2_Vstm2l,A2ACD2,Vstm2l,1,5,4,4,A2ACD2|Q6PDS0,MOUSE,22313.8,19.8,2137,2137.1,37.14,37.14,NA,202,V-set and transmembrane domain-containing protein 2-like protein,,,,4,5,1.14E+08,19.80%
1963,Q9CQU0,6.65E-05,-0.110166667,57.37909013,1.155,1.83E-06,12.89965337,-0.691,-0.649,-0.723,0.534,0.531,0.337,Q9CQU0,Txndc12,Q9CQU0_Txndc12,Q9CQU0,Txndc12,1,15,6,6,Q9CQU0,MOUSE,19219.4,44.1,1494,1494.1,71.12,71.12,NA,170,Thioredoxin domain-containing protein 12,endoplasmic reticulum lumen|,cell redox homeostasis|oxidation-reduction process|,protein-disulfide reductase (glutathione) activity|,6,15,4.03E+09,44.10%
973,Q8K1S1,0.0006831,0.039666667,44.46561655,1.151333333,3.58E-05,8.533065826,-0.464,-0.611,-0.533,0.805,0.32,0.721,Q8K1S1,Lgi4,Q8K1S1_Lgi4,Q8K1S1,Lgi4,1,34,14,14,Q8K1S1,MOUSE,60174.2,34.2,625,625.1,199.53,199.53,NA,537,Leucine-rich repeat LGI family member 4,extracellular space|,adult locomotory behavior|glial cell proliferation|Schwann cell development|glial cell development|myelination in peripheral nervous system|gliogenesis|neuron maturation|myelination|,protein binding|,14,34,5.68E+09,34.20%
2486,P45878,0.000319266,-0.049,48.67493657,1.137333333,1.36E-05,9.786103763,-0.474,-0.551,-0.828,0.628,0.419,0.512,P45878,Fkbp2,P45878_Fkbp2,P45878,Fkbp2,1,10,4,4,P45878,MOUSE,15514.8,20,2002,2002.1,42.5,42.5,NA,140,Peptidyl-prolyl cis-trans isomerase FKBP2,cytoplasm|endoplasmic reticulum membrane|extracellular exosome|,protein peptidyl-prolyl isomerization|chaperone-mediated protein folding|,peptidyl-prolyl cis-trans isomerase activity|FK506 binding|,4,10,5.74E+08,20.00%
2064,Q80Z10,0.002502375,-0.154666667,37.77611933,1.131333333,0.000166874,6.832622882,-0.856,-0.92,-0.385,0.628,0.236,0.369,Q80Z10,Astn2,Q80Z10_Astn2,Q80Z10,Astn2,1,7,6,6,Q80Z10|Q80Z10-2|Q80Z10-3,MOUSE,151727,5.6,1587,1587.1,63.7,63.7,NA,1352,Astrotactin-2,endosome|integral component of membrane|cell pole|,negative regulation of protein localization to cell surface|,protein binding|,6,7,3.39E+08,5.60%
1493,Q9EPR5,0.001911789,-0.195833333,39.06721943,1.123,0.000123959,7.122706211,-0.885,-0.999,-0.388,0.447,0.309,0.341,Q9EPR5,Sorcs2,Q9EPR5_Sorcs2,Q9EPR5,Sorcs2,1,12,9,9,Q9EPR5|Q8BI74,MOUSE,129984.1,9.4,1068,1068.1,115.41,115.41,NA,1159,VPS10 domain-containing receptor SorCS2,integral component of membrane|,,protein binding|,9,12,5.69E+08,9.40%
2176,Q8R0X7,0.000107976,-0.031166667,54.55247715,1.123,3.51E-06,11.80264738,-0.498,-0.567,-0.713,0.546,0.434,0.611,Q8R0X7,Sgpl1,Q8R0X7_Sgpl1,Q8R0X7,Sgpl1,1,12,7,7,Q8R0X7|D6REF7,MOUSE,64303.7,13.3,1696,1696.1,56.51,56.51,NA,568,Sphingosine-1-phosphate lyase 1,endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|,luteinization|vasculogenesis|kidney development|fatty acid metabolic process|ceramide metabolic process|nitrogen compound metabolic process|spermatogenesis|androgen metabolic process|estrogen metabolic process|female gonad development|post-embryonic development|fibroblast migration|hemopoiesis|sphingolipid catabolic process|Leydig cell differentiation|regulation of multicellular organism growth|platelet-derived growth factor receptor signaling pathway|skeletal system morphogenesis|palate development|face morphogenesis|apoptotic signaling pathway|,sphinganine-1-phosphate aldolase activity|carboxy-lyase activity|pyridoxal phosphate binding|,7,12,3.23E+09,13.30%
3264,Q5I012,0.000930376,0.037166667,42.72984363,1.113,5.33E-05,8.057089449,-0.417,-0.54,-0.601,0.553,0.354,0.874,Q5I012,Slc38a10,Q5I012_Slc38a10,Q5I012,Slc38a10,1,3,2,2,Q5I012|J3QNE8|Q5I012-2|Q5I012-3|Q5I012-4,MOUSE,117762.2,1.8,2801,2801.1,18.85,18.85,NA,1090,Putative sodium-coupled neutral amino acid transporter 10,Golgi apparatus|integral component of membrane|,amino acid transmembrane transport|sodium ion transport|bone development|,amino acid transmembrane transporter activity|,2,3,2.29E+11,1.80%
2189,A2ADH1,0.000159242,-0.015,52.21251387,1.108666667,6.01E-06,10.95935237,-0.523,-0.494,-0.691,0.6,0.396,0.622,A2ADH1,Magt1,A2ADH1_Magt1,A2ADH1,Magt1,1,11,5,5,A2ADH1|Q9CQY5|Q9CQY5-3|Q9CQY5-2,MOUSE,42036.4,17.6,1709,1709.1,55.82,55.82,NA,368,Magnesium transporter protein 1,oligosaccharyltransferase complex|membrane|,magnesium ion transport|cell redox homeostasis|cognition|,magnesium ion transmembrane transporter activity|,5,11,1.37E+10,17.60%
2747,Q9CZX9,0.011075124,0.0975,30.45505708,1.103666667,0.000900522,5.305398774,-0.505,-0.58,-0.278,1,0.165,0.783,Q9CZX9,Emc4,Q9CZX9_Emc4,Q9CZX9,Emc4,1,7,3,3,Q9CZX9,MOUSE,20287.5,20.7,2261,2261.1,32.76,32.76,NA,183,ER membrane protein complex subunit 4,integral component of membrane|ER membrane protein complex|,apoptotic process|,,3,7,2.21E+08,20.70%
1334,E9QNF7,4.72E-05,-0.129,59.7918633,1.098666667,1.05E-06,13.90949528,-0.677,-0.707,-0.651,0.484,0.398,0.379,E9QNF7,Cntnap2,E9QNF7_Cntnap2,E9QNF7,Cntnap2,1,18,14,14,E9QNF7|Q9CPW0,MOUSE,150244.3,12.2,923,923.1,137.71,137.71,NA,1332,Contactin-associated protein-like 2,early endosome|Golgi apparatus|voltage-gated potassium channel complex|cell surface|membrane|axolemma|juxtaparanode region of axon|,learning|striatum development|limbic system development|thalamus development|adult behavior|neuron projection development|social behavior|vocal learning|superior temporal gyrus development|protein localization to juxtaparanode region of axon|vocalization behavior|,protein binding|enzyme binding|,14,18,1.25E+09,12.20%
1023,Q06890,6.11E-05,-0.141666667,57.8891609,1.094,1.63E-06,13.1073012,-0.749,-0.714,-0.603,0.411,0.355,0.45,Q06890,Clu,Q06890_Clu,Q06890,Clu,1,44,12,12,Q06890,MOUSE,52282.3,26.1,663,663.1,189.04,189.04,NA,448,Clusterin,extracellular space|intracellular|nucleus|cytoplasm|mitochondrion|endoplasmic reticulum|cytosol|extracellular matrix|mitochondrial membrane|spherical high-density lipoprotein particle|chromaffin granule|perinuclear region of cytoplasm|extracellular exosome|blood microparticle|neurofibrillary tangle|apical dendrite|extracellular matrix|,cell morphogenesis|microglial cell activation|response to virus|protein import|central nervous system myelin maintenance|positive regulation of proteasomal ubiquitin-dependent protein catabolic process|negative regulation of protein homooligomerization|positive regulation of tumor necrosis factor production|positive regulation of apoptotic process|positive regulation of nitric oxide biosynthetic process|protein stabilization|positive regulation of NF-kappaB transcription factor activity|chaperone-mediated protein complex assembly|response to misfolded protein|chaperone-mediated protein folding|microglial cell proliferation|intrinsic apoptotic signaling pathway|regulation of beta-amyloid clearance|regulation of neuron death|positive regulation of neuron death|positive regulation of beta-amyloid formation|negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage|negative regulation of beta-amyloid formation|regulation of neuronal signal transduction|positive regulation of tau-protein kinase activity|positive regulation of neurofibrillary tangle assembly|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|positive regulation of intrinsic apoptotic signaling pathway|,protein binding|ubiquitin protein ligase binding|misfolded protein binding|ATPase activity|,12,44,1.40E+10,26.10%
2047,P29533,0.000111011,-0.140833333,54.35456224,1.073,3.67E-06,11.72912004,-0.744,-0.56,-0.728,0.313,0.412,0.462,P29533,NotFound,P29533_NotFound,P29533,Vcam1,1,7,5,5,P29533|Q3UPN1|P29533-2,MOUSE,82457.1,8.1,1571,1571.1,65.35,65.35,NA,739,Vascular cell adhesion protein 1,podosome|extracellular space|early endosome|endoplasmic reticulum|Golgi apparatus|microvillus|external side of plasma membrane|cell surface|integral component of membrane|filopodium|anchored component of membrane|apical part of cell|extracellular exosome|alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex|cell periphery|,cell adhesion|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|leukocyte cell-cell adhesion|cell-matrix adhesion|heart development|amine metabolic process|viral process|positive regulation of T cell proliferation|leukocyte tethering or rolling|oxidation-reduction process|embryonic placenta morphogenesis|chorio-allantoic fusion|visceral serous pericardium development|cellular response to glucose stimulus|,integrin binding|primary amine oxidase activity|cell adhesion molecule binding|,5,7,3.51E+08,8.10%
1114,O08532,0.000776925,-0.091,43.78701928,1.066,4.18E-05,8.344305462,-0.757,-0.698,-0.417,0.608,0.269,0.449,O08532,Cacna2d1,O08532_Cacna2d1,O08532,Cacna2d1,1,23,16,16,O08532|E9Q1X8|O08532-5|O08532-4|O08532-2|O08532-3|Q8C6Y3,MOUSE,125768.9,18,739,739.1,170.74,170.74,NA,1103,Voltage-dependent calcium channel subunit alpha-2/delta-1,voltage-gated calcium channel complex|sarcoplasmic reticulum|T-tubule|extracellular exosome|,calcium ion transport|regulation of ion transmembrane transport|regulation of calcium ion transport|calcium ion transmembrane transport|,voltage-gated calcium channel activity|calcium channel regulator activity|protein binding|metal ion binding|voltage-gated calcium channel activity|,16,23,7.10E+08,18.00%
1909,Q61207,0.000231714,-0.135833333,50.48373258,1.065666667,8.95E-06,10.37137006,-0.664,-0.81,-0.532,0.507,0.359,0.325,Q61207,Psap,Q61207_Psap,Q61207,Psap,1,11,6,6,Q61207|J3QPG5|K3W4L3|Q8BFQ1|E9PZ00,MOUSE,63303.9,14.3,1443,1443.1,75.18,75.18,NA,557,Prosaposin,extracellular space|nucleoplasm|nucleolus|mitochondrion|lysosome|Golgi apparatus|intracellular membrane-bounded organelle|extracellular exosome|,sphingolipid metabolic process|adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway|regulation of lipid metabolic process|regulation of MAPK cascade|positive regulation of MAPK cascade|developmental growth|prostate gland growth|epithelial cell differentiation involved in prostate gland development|cellular response to organic substance|negative regulation of hydrogen peroxide-induced cell death|,G-protein coupled receptor binding|,6,11,8.95E+08,14.30%
907,Q91YQ5,0.000785718,0.059333333,43.67060339,1.064666667,4.29E-05,8.312272135,-0.382,-0.408,-0.629,0.638,0.363,0.774,Q91YQ5,Rpn1,Q91YQ5_Rpn1,Q91YQ5,Rpn1,1,48,18,18,Q91YQ5,MOUSE,68698.2,32.8,567,567.1,215,215,NA,608,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1,endoplasmic reticulum membrane|rough endoplasmic reticulum|membrane|integral component of membrane|melanosome|,protein N-linked glycosylation via asparagine|,dolichyl-diphosphooligosaccharide-protein glycotransferase activity|poly(A) RNA binding|,18,48,1.04E+10,32.80%
924,Q9D666,0.000274324,-0.117,49.43346932,1.059333333,1.14E-05,10.0279245,-0.661,-0.805,-0.474,0.489,0.359,0.39,Q9D666,Sun1,Q9D666_Sun1,Q9D666,Sun1,1,25,15,1,Q9D666|Q9D666-4|Q9D666-3|Q9D666-5|Q3TSM1,MOUSE,102830.3,22.6,580,580.1,211.31,15.94,NA,913,SUN domain-containing protein 1,acrosomal membrane|nucleus|nuclear envelope|integral component of nuclear inner membrane|cytoplasm|integral component of membrane|nuclear membrane|LINC complex|intracellular membrane-bounded organelle|nucleolus|,nuclear envelope organization|synapsis|cytoskeletal anchoring at nuclear membrane|nuclear matrix anchoring at nuclear membrane|,protein binding|lamin binding|,15,25,2.27E+09,22.60%
3001,P98156,0.000494052,-0.058,46.20018264,1.057333333,2.40E-05,9.031809524,-0.369,-0.682,-0.709,0.548,0.351,0.513,P98156,Vldlr,P98156_Vldlr,P98156,Vldlr,1,3,3,3,P98156|Q91YY0|F8WGI9|F8WIN7,MOUSE,100193.7,3.4,2513,2513.1,24.91,24.91,NA,873,Very low-density lipoprotein receptor,extracellular space|nucleus|coated pit|cell surface|membrane|integral component of membrane|very-low-density lipoprotein particle|receptor complex|apical part of cell|perinuclear region of cytoplasm|,negative regulation of transcription from RNA polymerase II promoter|lipid transport|receptor-mediated endocytosis|heart development|response to nutrient|cholesterol metabolic process|ventral spinal cord development|cerebral cortex development|cellular response to insulin stimulus|glycoprotein transport|very-low-density lipoprotein particle clearance|reelin-mediated signaling pathway|cellular response to glucose starvation|response to drug|positive regulation of protein kinase activity|dendrite morphogenesis|cellular response to lipopolysaccharide|cellular response to interleukin-1|cellular response to hypoxia|positive regulation of dendrite development|,glycoprotein binding|calcium ion binding|protein binding|very-low-density lipoprotein particle receptor activity|apolipoprotein binding|very-low-density lipoprotein particle binding|glycoprotein transporter activity|reelin receptor activity|calcium-dependent protein binding|,3,3,30100000,3.40%
1785,Q8VEF1,0.000447218,-0.1375,46.84722814,1.055,2.07E-05,9.224047648,-0.538,-0.901,-0.556,0.426,0.353,0.391,Q8VEF1,Gramd1a,Q8VEF1_Gramd1a,Q8VEF1,Gramd1a,1,10,7,7,Q8VEF1|Q8VEF1-3|F8WJ74|Q8VEF1-2|A0A087WP91,MOUSE,81382.4,12,1327,1327.1,84.9,84.9,NA,722,GRAM domain-containing protein 1A,integral component of membrane|,,,7,10,7.44E+08,12.00%
969,P24369,0.000477174,-0.115333333,46.48396145,1.054,2.25E-05,9.115697057,-0.408,-0.753,-0.766,0.375,0.481,0.379,P24369,Ppib,P24369_Ppib,P24369,Ppib,1,53,17,17,P24369,MOUSE,23713,61.1,621,621.1,200.35,200.35,NA,216,Peptidyl-prolyl cis-trans isomerase B,nucleus|endoplasmic reticulum|endoplasmic reticulum lumen|smooth endoplasmic reticulum|focal adhesion|membrane|macromolecular complex|endoplasmic reticulum chaperone complex|melanosome|perinuclear region of cytoplasm|extracellular exosome|,protein peptidyl-prolyl isomerization|positive regulation of multicellular organism growth|positive regulation by host of viral process|positive regulation by host of viral genome replication|protein stabilization|bone development|chaperone-mediated protein folding|,peptidyl-prolyl cis-trans isomerase activity|protein complex binding|peptide binding|poly(A) RNA binding|RNA polymerase binding|collagen binding|,17,53,1.50E+10,61.10%
2248,Q6DFY8,0.00161498,-0.162333333,39.93293565,1.051333333,0.000101556,7.335436334,-0.901,-0.757,-0.406,0.509,0.363,0.218,Q6DFY8,Brinp2,Q6DFY8_Brinp2,Q6DFY8,Brinp2,1,6,5,2,Q6DFY8|A0A0A6YWU9,MOUSE,90652.6,9,1767,1767.1,52.61,18.33,NA,783,BMP/retinoic acid-inducible neural-specific protein 2,extracellular region|,cell cycle arrest|positive regulation of neuron differentiation|negative regulation of mitotic cell cycle|cellular response to retinoic acid|,,5,6,1.15E+09,9.00%
1243,Q6P9K9,0.001162119,-0.053166667,41.48502123,1.046333333,7.10E-05,7.72923387,-0.674,-0.657,-0.398,0.687,0.243,0.48,Q6P9K9,Nrxn3,Q6P9K9_Nrxn3,Q6P9K9,Nrxn3,1,2,5,2,Q6P9K9|E9Q2X2|Q6P9K9-2|A0A087WPQ9,MOUSE,175479.1,2.9,845,845.2,56.73,14.35,NA,1571,Neurexin-3,integral component of membrane|presynaptic membrane|protein complex|,cell adhesion|synaptic transmission|neurotransmitter secretion|synapse assembly|learning|adult behavior|social behavior|positive regulation of synapse assembly|vocalization behavior|positive regulation of synapse maturation|,calcium channel regulator activity|protein binding|metal ion binding|,2,2,28700000,1.20%
3334,Q9R1V4,0.000857479,-0.160666667,43.19058052,1.045333333,4.80E-05,8.181252442,-0.799,-0.83,-0.421,0.414,0.247,0.425,Q9R1V4,Adam11,Q9R1V4_Adam11,Q9R1V4,Adam11,1,2,2,2,Q7TQG7|Q9R1V4,MOUSE,86643.3,3.6,2884,2884.1,17.53,17.53,NA,773,Disintegrin and metalloproteinase domain-containing protein 11,integral component of membrane|,proteolysis|,metalloendopeptidase activity|protein binding|zinc ion binding|,2,2,4.89E+08,3.60%
2221,Q9WU40-2,0.002010156,-0.172833333,38.78486854,1.043666667,0.000132286,7.054362729,-0.416,-1.02,-0.648,0.354,0.376,0.317,Q9WU40,Lemd3,Q9WU40-2_Lemd3,Q9WU40-2,Lemd3,1,6,5,5,Q9WU40-2|D3YU56|Q9WU40|E9QP59,MOUSE,103764.6,8.4,1740,1740.1,54.31,54.31,NA,921,Isoform 2 of Inner nuclear membrane protein Man1,nuclear envelope|nuclear inner membrane|integral component of nuclear inner membrane|integral component of membrane|,angiogenesis|blood vessel endothelial cell migration involved in intussusceptive angiogenesis|nucleus organization|negative regulation of transforming growth factor beta receptor signaling pathway|negative regulation of BMP signaling pathway|negative regulation of activin receptor signaling pathway|skeletal muscle cell differentiation|regulation of cell cycle|regulation of extracellular matrix organization|,nucleotide binding|DNA binding|,5,6,2.61E+08,8.40%
2342,Q9JK53,0.001456509,0.057666667,40.42206316,1.040666667,9.07E-05,7.457791879,-0.552,-0.354,-0.482,0.635,0.29,0.809,Q9JK53,Prelp,Q9JK53_Prelp,Q9JK53,Prelp,1,10,5,5,Q9JK53,MOUSE,43634,11.9,1859,1859.1,48.79,48.79,NA,378,Prolargin,proteinaceous extracellular matrix|extracellular exosome|extracellular vesicle|extracellular matrix|,cell aging|,extracellular matrix structural constituent|heparin binding|,5,10,2.00E+09,11.90%
1967,Q8BXQ2,0.000494052,-0.031,46.24579903,1.038666667,2.37E-05,9.045249794,-0.553,-0.638,-0.46,0.65,0.28,0.535,Q8BXQ2,Pigt,Q8BXQ2_Pigt,Q8BXQ2,Pigt,1,12,7,7,Q8BXQ2|B7ZC19,MOUSE,66388,12.7,1497,1497.1,71,71,NA,582,GPI transamidase component PIG-T,cytoplasm|membrane|cytoplasmic membrane-bounded vesicle|GPI-anchor transamidase complex|,attachment of GPI anchor to protein|neuron differentiation|neuron apoptotic process|,GPI-anchor transamidase activity|,7,12,6.57E+09,12.70%
370,P23818,0.002813209,0.036833333,37.13629171,1.035666667,0.000193362,6.665176411,-0.605,-0.49,-0.348,0.776,0.213,0.675,P23818,Gria1,P23818_Gria1,P23818,Gria1,1,25,20,14,P23818|F6YNQ1,MOUSE,102366,25,199,199.2,231.48,141.56,NA,907,Glutamate receptor 1,endoplasmic reticulum|endoplasmic reticulum membrane|plasma membrane|synaptic vesicle|ionotropic glutamate receptor complex|cell surface|postsynaptic density|membrane|cell junction|dendrite|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid selective glutamate receptor complex|dendrite membrane|dendritic spine membrane|neuron projection|neuronal cell body|dendritic spine|axonal spine|neuron spine|synapse|postsynaptic membrane|recycling endosome|,"synaptic transmission|long-term memory|receptor internalization|ion transmembrane transport|ionotropic glutamate receptor signaling pathway|synaptic transmission, glutamatergic|long term synaptic depression|",alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity|extracellular-glutamate-gated ion channel activity|protein binding|,14,25,3.12E+09,18.70%
2920,Q62351,0.000563379,-0.098166667,45.50102522,1.025,2.82E-05,8.827914096,-0.432,-0.843,-0.557,0.381,0.415,0.447,Q62351,Tfrc,Q62351_Tfrc,Q62351,Tfrc,1,3,3,3,Q62351|Q8C872,MOUSE,86129.2,4.8,2433,2433.1,26.97,26.97,NA,763,Transferrin receptor protein 1,extracellular region|extracellular space|mitochondrion|endosome|plasma membrane|coated pit|external side of plasma membrane|cell surface|membrane|integral component of membrane|cytoplasmic membrane-bounded vesicle|melanosome|intracellular membrane-bounded organelle|perinuclear region of cytoplasm|recycling endosome|recycling endosome membrane|extracellular exosome|blood microparticle|extracellular vesicle|HFE-transferrin receptor complex|,response to hypoxia|cellular iron ion homeostasis|receptor-mediated endocytosis|acute-phase response|aging|response to nutrient|response to manganese ion|osteoclast differentiation|cellular response to extracellular stimulus|response to retinoic acid|transferrin transport|iron ion transmembrane transport|cellular response to drug|positive regulation of bone resorption|response to copper ion|cellular response to iron ion|iron ion import|,glycoprotein binding|double-stranded RNA binding|transferrin receptor activity|iron ion transmembrane transporter activity|protein binding|Hsp70 protein binding|transferrin transmembrane transporter activity|identical protein binding|poly(A) RNA binding|chaperone binding|,3,3,68200000,4.80%
3052,Q99JH7,0.047072696,-0.236833333,22.88258429,1.019666667,0.005149221,3.904154965,-1.164,-0.947,-0.129,0.171,0.54,0.108,Q99JH7,Clstn3,Q99JH7_Clstn3,Q99JH7,Clstn3,1,3,3,3,Q99JH7|D3Z601,MOUSE,107182.6,3.8,2570,2570.1,23.55,23.55,NA,956,Calsyntenin-3,Golgi membrane|endoplasmic reticulum membrane|cell surface|integral component of membrane|protein complex|postsynaptic membrane|extracellular exosome|neuronal postsynaptic density|,"regulation of cell growth|homophilic cell adhesion via plasma membrane adhesion molecules|synapse assembly|synaptic transmission, glutamatergic|positive regulation of synaptic transmission|synaptic transmission, GABAergic|positive regulation of synapse assembly|positive regulation of protein localization to synapse|",calcium ion binding|protein binding|,3,3,2.01E+08,3.80%
1850,P37040,0.000139811,-0.054166667,52.91447461,1.011666667,5.11E-06,11.20645173,-0.443,-0.657,-0.58,0.46,0.392,0.503,P37040,Por,P37040_Por,P37040,Por,1,9,7,7,P37040|Q05DV1,MOUSE,77441.9,15,1388,1388.1,79.99,79.99,NA,678,NADPH--cytochrome P450 reductase,mitochondrion|endoplasmic reticulum membrane|cytosol|membrane|intracellular membrane-bounded organelle|,regulation of growth plate cartilage chondrocyte proliferation|response to nutrient|carnitine metabolic process|flavonoid metabolic process|internal peptidyl-lysine acetylation|fatty acid oxidation|positive regulation of chondrocyte differentiation|positive regulation of monooxygenase activity|response to drug|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|nitrate catabolic process|positive regulation of cholesterol biosynthetic process|positive regulation of smoothened signaling pathway|nitric oxide catabolic process|oxidation-reduction process|negative regulation of lipase activity|demethylation|cellular response to follicle-stimulating hormone stimulus|cellular response to peptide hormone stimulus|positive regulation of steroid hormone biosynthetic process|cellular organofluorine metabolic process|,"NADPH-hemoprotein reductase activity|cytochrome-b5 reductase activity, acting on NAD(P)H|iron ion binding|nitric oxide dioxygenase activity|electron carrier activity|FMN binding|oxidoreductase activity|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen|hydrolase activity|enzyme binding|iron-cytochrome-c reductase activity|flavin adenine dinucleotide binding|NADP binding|",7,9,6.35E+08,15.00%
381,E9Q616,7.11E-05,-0.097,56.82088998,1.007333333,2.08E-06,12.67588844,-0.544,-0.636,-0.622,0.362,0.409,0.449,E9Q616,Ahnak,E9Q616_Ahnak,E9Q616,Ahnak,1,59,41,40,E9Q616,MOUSE,605040.9,9.5,205,205.1,453.05,432.55,NA,5656,AHNAK nucleoprotein (desmoyokin),nucleus|cytoplasm|lysosomal membrane|cytosol|plasma membrane|cell-cell junction|focal adhesion|actin cytoskeleton|membrane|vesicle|sarcolemma|costamere|cell-cell contact zone|extracellular exosome|T-tubule|membrane raft|,regulation of RNA splicing|protein oligomerization|regulation of voltage-gated calcium channel activity|,S100 protein binding|poly(A) RNA binding|structural molecule activity conferring elasticity|,40,59,9.53E+09,9.00%
982,P43276,0.009714953,0.01,31.11889497,1,0.000772877,5.440066511,-0.167,-0.46,-0.843,0.345,0.438,0.747,P43276,Hist1h1b,P43276_Hist1h1b,P43276,Hist1h1b,1,10,7,5,P43276,MOUSE,22575.7,30.4,631,631.4,95.36,77.75,NA,223,Histone H1.5,nucleosome|nucleus|,nucleosome assembly|muscle organ development|,DNA binding|protein binding|,5,10,1.08E+09,23.70%